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CHAPTER 1
Introduction
Although

more

than

50%

of

colon

cancer

patients

undergoing

laparoscopic or open surgical procedures have viable colon tumor cells free in
the peritoneum, only ~1% of these patients experience wound implantation
[1,2,3,4,5]. In addition, only a fraction of patients with apparently resectable colon
cancer will go on to experience metastasis at a distant site, approximately 33%. It
is known that both wound implantation and metastasis require cell adhesion to
the extracellular matrix and/or endothelium followed by rapid proliferation.
However, this information suggests that the great majority of tumor cells never
adhere [6]. For patients in whom errant tumor cells do adhere, the consequences
may be radical surgery or possibly death. This unfortunate paradigm emphasizes
the need to study the mechanisms underlying the cell adhesion and proliferation
processes.
Previous studies have indicated that pressure stimulated adhesion is β1
integrin dependent [7]. Integrins are heterodimeric receptors embedded in the
cell membrane that are composed of an α and a β subunit that are involved in
cytoskeletal attachment to the extracellular matrix [8]. Integrins have no catalytic
activity; however, their location within the membrane gives them the opportunity
to participate in bi-directional signaling [9]. The ligands for integrins are
components of the extracellular matrix, including laminin and collagen. Signaling
initiated through extracellular ligand binding and/or ligand-induced integrin
clustering is termed “outside-in” signaling, and may induce changes in
cytoskeletal organization, protein phosphorylation and gene expression. Integrin
affinity and avidity may both be modulated through the activation of “inside-out”
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cytoplasmic signaling events that cause conformational changes in the
extracellular ligand-binding sites (affinity) and cytoskeletal induced integrin
clustering (avidity) [10]. Mediation of these properties provides an internal control
over cell adhesiveness. Integrin-dependent cell adhesion has been shown to
regulate colorectal carcinoma organ-specific metastasis through both changes in
surface expression and alterations in integrin affinity [11,12].
Once a cell attaches to the extracellular matrix, integrin clustering leads to
autophosphorylation and activation of focal adhesion kinase at tyrosine 397. This
phosphorylation promotes the activation of intracellular signaling cascades. The
phosphorylation of focal adhesion kinase at tyrosine 397 creates a high affinity
binding site for the SH2 domain of Src family members [13]. Src is recruited and
phosphorylated and leads to further phosphorylation of focal adhesion kinase at
tyrosines 576 and 577 [14]. The C-terminal region of focal adhesion kinase
contains proline rich sequences that give other molecules, such as p130Cas , the
ability to bind. The binding of these molecules lead to activation of Rac and Rho
GTPases and influence cell migration and many other diverse cellular processes
[15].
In 2000, Basson et al. reported that colon cancer cells adhere to collagen
and endothelial cells upon exposure to 15mmHg increased pressure for 30
minutes. This result was confirmed in four colon cancer cell lines (SW620, Caco2, HT-29, SW1116), as well as primary tumor cells from 20 colon cancer patients
[7]. These results are clinically relevant, as patients are exposed to increases in
pressure during laparoscopic insufflation, surgical manipulation and post
operative edema [16]. Furthermore, additional evidence indicated that increasing
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pressure to the same extent caused breast cancer cell adhesion to collagen [17].
These results are also clinically relevant, as studies have shown that breast
tumors can experience intratumoral pressures exceeding 29mmHg [18,19].
In contrast to “outside in” signaling that occurs upon ligand binding to
integrin receptors, “inside out” signaling causes internal activation of signaling
cascades. “Inside out” signaling is β1 integrin dependent and can be influenced
by various cations [7,20]. Cellular adhesion occurs without increased surface
expression of β1 integrin, which suggests that receptor affinity modulation may
be responsible for the pressure effect [21]. SW620 cells exposed to elevated
pressure that are unable to adhere show activation of focal adhesion kinase at
tyrosine 397, as well as Src activation. In addition, inhibiting focal adhesion
kinase by specific siRNA or inhibiting Src using PP2, completely abrogated the
pressure effect [21]. Further studies confirmed that an intact cytoskeleton is
necessary for pressure stimulated adhesion. When the cytoskeleton is
compromised by agents including colchicines, phalloidin and cytochalasin D, the
pressure effect is abolished. Using these inhibitors, it was determined that Src
phosphorylation is cytoskeleton independent, as Src phosphorylation continues
to take place in the presence of cytoskeletal inhibitors. Focal adhesion kinase, on
the other hand, does not become phosphorylated in the presence of these
inhibitors [22]. Recent data also shows that PI3 kinase inhibitors (LY294002 and
wortmannin), siRNA treatment to reduce Akt, and Akt inhibitors each also block
pressure stimulated cell adhesion in SW620 cells as well as human primary
tumor cells. Pressure was shown to activate PI3 kinase and phosphorylate Akt.
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Pressure also stimulates the relocation of focal adhesion kinase to the cell
membrane, except in the presence of Akt inhibitor IV [23]. While several
molecules have been identified in the pressure stimulated adhesion pathway, the
overall mechanism is still poorly understood. Paxillin may prove to be important
in this pathway, as it is involved in focal adhesion complex assembly and linkage
of the focal adhesion complex to integrins and the cytoskeleton.
Paxillin is a 68-kDa focal adhesion protein that has been implicated in
diverse cellular events including cellular motility, cell spreading, embryogenesis,
intracellular signaling pathways, and apoptosis [24]. Several types of cancer,
including head and neck cancers and human osteosarcomas have shown
increased paxillin expression relative to their normal counterparts [25]. Paxillin
acts as a multi-domain adaptor protein that is found at the interface between the
plasma membrane and the actin cytoskeleton. The carboxyl terminus of paxillin
consists of four LIM domains arranged in tandem. The LIM3 domain is known to
anchor paxillin to the plasma membrane, and though the exact mechanism is not
entirely known, in vitro and in vivo co-precipitation studies have shown that
paxillin co-precipitates with the cytoplasmic tail of β1 integrin [26]. The amino
terminus of paxillin contains the SH2 and SH3 domains which may contain the
binding site for Src, and lead to Src localization to focal adhesions. Focal
adhesion kinase is known to phosphorylate paxillin at two main sites; tyrosine 31
and tyrosine 118 [27]. Upon this phosphorylation by focal adhesion kinase, two
functional SH2 binding sites are generated for members of the Crk family of
adaptor proteins to bind. This complex of paxillin and a Crk creates a docking site
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for another focal adhesion protein; p130Cas [28]. This complex of paxillin, Crk and
p130Cas has been shown to be necessary for integrin-mediated cell motility
through activation of Rac and Rho family members [29,30].
In addition to increasing cancer cell adhesion, Walsh et al illustrated that
24 hours of increased pressure also induces colon cancer cell proliferation on
fibronectin and collagen. This effect was observed beginning at six hours and
continued for 24 hours. During this time, proliferation was increased 46% and the
percentage of cells in S-phase was also elevated approximately 20% relative to
cells that remained in ambient pressure conditions. In a manner similar to that
observed when short term pressure stimulates adhesion, 24 hours of pressure
increased phosphorylation of Src, MEK and p38. However, in contrast, Akt
phosphorylation was not increased. Additional differences were observed when
pharmacological inhibition of PI-3-kinase, actin depolymerization, Src, p38 and
MEK did not abolish the effect of pressure on cellular proliferation. It was further
determined that inhibition of protein kinase C was sufficient to abolish pressure
stimulated proliferation [31].
Protein kinase C is a family of enzymes that serve many diverse functions
and are known to stay activated for extended periods of time. Protein kinase C
regulates cellular functions such as adhesion, migration, and immune cell
regulation. Some protein kinase C isoforms can also regulate NF-kB activation as
well as cellular proliferation [32,33].
NF-kB is a rapidly acting transcription factor that modulates gene
transcription in cell-cycle regulation, apoptosis, and proliferation. NF-kB signaling
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is complex, and can promote proliferation through increased expression of cell
cycle regulators, or cell death through interactions with anti-apoptotic factors
such as FLIP and TRAF1/2 [34]. NF-kB family members share a Rel homology
domain in their N-terminus. However, RelA, RelB and c-Rel are the only
members with transactivation domains. NF-kB family members form homodimers
or heterodimers to participate in transactivation. RelA, the p65 subunit, regulates
transcription directly, as it has a nuclear translocation sequence in addition to a
direct DNA binding site. Traditional NF-kB signaling involves heterodimerization
between RelA and p50. NF-kB can promote or inhibit apoptosis depending upon
the stimulus [35].
Aberrant or constitutive NF-kB activation characterizes many human
malignancies and indicates poor prognosis in colorectal and esophageal cancers
[34,36,37]. Additionally, other studies have found that NF-kB immunoreactivity of
correlates with poor prognosis in various cancers [38].
Based on these previous observations, we hypothesized that paxillin,
protein kinase C and NF-kB may be necessary molecules in the cellular signaling
that occurs as pressure stimulates adhesion or proliferation. We assessed the
role of these molecules in various cancer cell lines and further evaluated the
effect of pressure on distant metastasis using an in vivo murine model. These
pathways may represent a target of opportunity to inhibit adhesion and
metastasis, as well as slow the growth of unresectable tumors or tumors not
candidates for conventional cytotoxics.
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CHAPTER 2
Materials and Methods
Cell Culture. For initial characterization of CARP-1, estrogen receptornegative, p53 negative MDA-MB-468 human breast cancer cells were used.
These cells were cultured and maintained using Dulbecco’s modified Eagle
medium, Ham’s F-12 medium and fetal bovine serum. All studies involving
CARP-1 utilized these cells. SW620 and Caco-2 colon cancer cell lines, MCF-7
breast cancer and PC3 prostate cancer cell lines were obtained from the
American Type Culture collection (Rockville, MD), and cultured according to the
manufacture’s recommendation. The luciferase-tagged CT-26 murine colon
cancer cell line (Caliper Life Sciences, Hopkinton, MA) was cultured using 600
µg/mL geneticin. Primary human colon cancer cells were obtained from surgically
resected specimens that were minced and collagenase digested into single cell
suspensions. Viability of the isolated colonocytes was determined to be over 90%
by trypan blue exclusion. The Wayne State University Human Investigation
Committee approved the use of all human samples.
Mice. Balb/c mice were used for all in vivo tumor studies, as well as long
term survival studies. All animal procedures were conducted with the approval of
the Wayne State University Animal Investigation Committee and the John D.
Dingell VA Medical Center Research and Development Committee.
Pressure Regulation. Pressure was regulated using an airtight Lucite
box that was pre-warmed to 37°C to prevent internal fluctuations. The box
contained an inlet and outlet valve for gas application and a manometer
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connection, respectively. Temperature was regulated to within ± 2ºC and
pressure was maintained to within 1.5 mmHg. Cells were placed in the pressure
box from 30 minutes to 72 hours depending on the study under investigation.
Ambient pressure control plates were placed in identical incubation conditions for
the same duration of time.
Pressure Measurements of Intraabdominal Malignant Tumors. Under
IRB-approved protocol, we measured interstitial pressure during image-guided
biopsy just outside of 13 human tumors using a Transpac IV Monitoring Kit
pressure transducer (Hospira, Lake Forest, IL) attached to a coaxial needle
which was then advanced into the tumor for a second measurement. Pressure
was measured during routine biopsies of tumors subsequently confirmed to be
malignant but before removing biopsied tissue.
Cell Adhesion Assay.

SW620 cells in suspension were placed in

collagen I (Sigma, St. Louis, MO) pre-coated 6 well plates for 30 minutes under
ambient or 15 mmHg increased pressure conditions in a 37°C incubator (10 5
cells/well). After 30 minutes the non-adherent cells were washed away with
phosphate buffered saline solution and the adherent cells were fixed with
formalin and stained with hematoxylin. Each well was divided into 20 random,
individual, high-power fields and cells were counted in each field using an
inverted microscope[7].
To determine adhesion of SW620 cells that were transfected with the
paxillin plasmid phosphorylation mutants or p130cas rescue plasmid, 48 hours
post transfection the cells were plated in collagen I precoated 6 well plates as
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described above. After 30 minutes of ambient or 15mmHg increased pressure,
the non-adherent cells were washed away and the adherent cells were
permeablized and incubated overnight with antibody to myc or human influenza
hemagglutinin (HA) depending upon the tag of the mutant. After 24 hours, the
myc or HA antibody was removed, the cells were washed with phosphate
buffered saline solution and Texas Red (Amersham Pharmacia Biotech,
Piscataway, NJ) was added for 1 hour. The cells were then counted under a
fluorescence microscope.
Proliferation Assay.

5,000 cells per well were seeded in collagen I

precoated 96-well plates. Various inhibitors were added at the concentrations
listed in Table 1. Cells were exposed to increased or ambient pressure for 24
hours. After 24 hours, MTT reagent was added and cells were incubated for 2-4
hours at 37°C. Finally, the cells were treated with a detergent reagent overnight.
The plates were then read on a fluorescence plate reader at 570 nm.
Transfection. For studies involving CARP-1, MDA-MB-468 human breast
cancer cells were transfected with vector plasmids pcDNA3, pcDNA3/Hygro,
pcDNA3/Hygro CARP-1 antisense clone 1.6, or pcDNA3/CARP-1-myc-His clone
6.16. For stable transfections, this was followed by selection using 800 µg/mL of
neomycin or 400 µg/mL of hygromycin. From this, multiple resistant stable sublines were generated and propagated.
Myc tagged wild type and Y31Y118 paxillin plasmid mutants were
compliments of Dr. M. Cecilia Subauste. HA tagged wild type, as well as Y31,
Y118, Y181 and Y31Y118Y181 paxillin plasmid mutants were generous gifts of
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Dr. Ravi Salgia. All mutants had a Y

F mutation on their respective tyrosine

residues. Using Lipofectamine 2000 (Invitrogen, Carlsbad, CA), SW620 cells
were transfected with 2 µg/ml of plasmids expressing myc tagged wild type or
Y31Y118 mutant, or HA tagged wild type, Y31, Y118, Y181, or Y31Y118Y181
mutants.
Additionally, total Crk, p130cas, α-actinin and FAK levels were reduced
using small interfering RNA SMARTpools® produced by Dharmacon (Lafayette,
CO), as well as oligofectamine and plus reagent according to the manufacturer’s
protocol (Invitrogen, Carlsbad, CA). NF-kB p65 protein levels were reduced using
NF-kB specific small interfering siRNA (Cell Signaling), as well as lipofectamine
2000 (invitrogen) as recommended by the manufacture. Crk, p130cas and FAK
expression

was

reduced

ACACTATTTGGACACTACA-3’

using
segment

siRNA
of

targeting
Crk

mRNA,

the
the

5’5’-

GGTCGACAGTGGTGTGTAT-3’ segment of p130cas mRNA and the 5’AAGCAUGUGGCCUGCUAUGGA-3’ segment of FAK mRNA. A Dharmacon
siCONTROL® non-targeting siRNA #1 was used as a control. Scrambled siRNA
sequences for paxillin, Crk and Cas were also used as a control. The scrambled
sequences used were:

paxillin 5’-TGGTGTCTTCCGTTTAGGG-3’, Crk 5’-

ATATAAGCAGCGTGATTCC-3’ and Cas 5’-CAGTGATGGTATGTGCGGT-3’. All
experiments were performed 48 hours post transfection.
Rac1 Activation Assay. Rac1 activity was assessed using a pulldown
assay (Millipore, Billerica, MA).

SW620 cells were grown to confluence and

plated on dishes pre-coated with 1% heat inactivated BSA. They were then
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exposed to ambient or 15 mmHg increased pressure as described above. Cells
were collected by centrifugation and lysed using lysis buffer provided by the
manufacturer.

Protein concentrations were determined by the BCA method.

Active Rac1 levels were determined by GST-PBD (glutathione S-transferaseconjugated p21 binding domain) of p21-activated kinase 1 pulldown assays. The
cell lysates were incubated with PAK-PBD beads for 1 hour at 4 °C on a rotator,
and the beads were pelleted by centrifugation at 5000 x g for 2 min at 4 °C. The
resulting

pellet

was

then

resuspended

in

Laemmli

buffer

resolved

electrophoretically, transferred to nitrocellulose, and immunoblotted with
monoclonal anti-Rac1 antibody (Pierce). Additionally, 20 µg of cell lysates were
used for Western blotting for total Rac1.
Inhibitor Studies.

The Src family kinase inhibitor PP2 (Calbiochem,

Gibbstown, NJ) was dissolved in dimethyl sulfoxide (Me2SO) and diluted in cell
culture medium immediately prior to use. SW620 cells were treated with 65 nM of
PP2 or an equivalent amount of Me2SO (vehicle control) for 1 hour prior to
adhesion or signaling studies. 30 nM of PP2 was added to cells for 24 hours
during cellular proliferation studies and NF-kB activation studies. NSC23766
(Calbiochem, Gibbstown, NJ), an inhibitor of Rac1 activation was dissolved in
sterile distilled water and diluted in cell culture medium immediately prior to use.
SW620 cells were treated with 50 µM NSC23766 or cell culture medium (vehicle
control) for 1 hour prior to adhesion or signaling studies. 30 µM NSC23766 was
added to the cells for 24 hours during cellular proliferation studies and NF-kB
activation studies.
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To further determine molecular signaling involved in pressure stimulated
proliferation and NF-kB activation, selected inhibitors were dissolved in sterile
phosphate buffered saline solution, dimethyl sulfoxide or water according to the
manufacture’s protocol. Cells were treated with each inhibitor for 24 hours. Akt
was inhibited using the 1 µM Akt inhibitor IV (EMD Chemicals, Gibbstown, NJ).
NF-kB p50 nuclear localization was blocked with 12 µM SN50 (EMD Chemicals),
in parallel with an SN50 inactive analog that does not affect NF-kB nuclear
translocation. The NF-kB serine 276 inhibitory peptide (25 µM, Imgenex, San
Diego, CA) acts as an NF-kB p65 nuclear decoy through phosphorylation at that
site. Cells were treated with the inhibitory peptide of an inactive control. TCH021, a novel imidazoline inhibitor, was a generous gift from our collaborator, Dr.
Jetze Tepe. It was used (5 µM) to inhibit NF-kB gene transcription by modulating
IkB degradation and subsequently inhibiting NF-kB DNA binding.
PKC was blocked globally using Calphostin C (100 nM). Inhibition of PKCα and PKC-β was achieved using Go6976 (6 nM). PKC-β alone was inhibited
using

3-(1-(3-Imidazol-1-ylpropyl)-1H-indol-3-yl)-4-anilino-1H-pyrrole-2,5-dione

(15 nM). Finally, the PKC-ε subunit was inhibited using a translocation inhibitory
peptide (10 nM).
To evaluate the role of the IKK complex subunits on pressure-stimulated
proliferation,

the

IKK-2

inhibitor

[5-(p-fluorophenyl)-2-ureido]-thiophene-3-

carboxamide (10 mM), IKK-3 inhibitor [5-(5,6-dimethoxybenzinidazol-1-yl)-3-(2methanesulfonyl-benzyloxy)-thiophene-2-carbonitrile] (40 nM) and the IKK
inhibitor N-(6-chloro-9H-β-carbolin-8-yl)-nicotinamide (90 nM), that blocks IkB

13
phosphorylation, were used per manufacturer’s protocol, separately and in
combination (EMD Chemicals). Table 1 lists all inhibitors used.
Flow Cytometric Analysis.

To evaluate cellular proliferation, cells

exposed to pressure for 24 hours were detached using trypsin/EDTA and fixed in
90% ice cold ethanol. The cells were then stained with propidium iodide (5 µg/mL
PBS, pH 7.4, containing 200 µg/mL DNase free Rnase A and 0.1% Triton-X 100).
Transition to S-phase was evaluated using a FACSCalibur flow cytometer (BD
Bioscience) and FlowJo software (Tree Star). Assays were performed on cells
following 24 hours of serum starvation to induce cellular quiescence.
To evaluate in vivo molecular signaling following cardiac puncture,
isolated, CFSE labeled cells were fixed with 4% paraformaldehyde for 10
minutes and washed with a staining buffer that contained 0.2% bovine serum
albumin and 0.02% sodium azide in phosphate buffered saline. Cells were then
incubated with anti-FAK, anti-Akt, and anti-mouse CD29 (9EG7) for 30 minutes
at 4ºC. Following antibody incubation, cells were washed twice with staining
buffer and analyzed using the system and software stated above at the Wayne
State University School of Medicine Flow Cytometry Core Facility.
TUNEL Staining.

Cells were plated on collagen I pre-coated glass

coverslips and exposed to increased or ambient pressure conditions for 24
hours. Proteinase K digestion was performed followed by peroxidase blocking.
Coverslips were incubated with TdT reaction buffer and reaction mixture and
detected using streptavadin-HRP and DAB. Hematoxylin was used as a
counterstain and the slides were coversliped using a xylene based mounting
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medium. Apoptotic cells were counted on each slide and control and pressure
treated cells were compared (TUNEL staining kit, Roche Applied Science,
Indianapolis, IN).
NF-kB Activity Assay.

Cellular NF-kB activity was assayed using a

luciferase-based NF-kB lentiviral reporter assay (Qiagen, Frederick, MD). 5,000
cells/well were plated in 96 well plates for 24 hours and lentiviral particles were
introduced with SureENTRY transduction reagent (2 µg/mL, Qiagen) for 24
hours. The lentiviral suspension was replaced with normal medium, and cells
were exposed to ambient or increased pressure for 24 hours. Luciferin was
added using the bright-glow luciferase assay (Promega, Madison, WI) and
luminescence quantitated by a FLUOstar Omega plate reader (BMG LabTech,
Offenburg, Germany).
Nuclear Fractionation.

Cytosolic and nuclear fractions wee obtained

using the Qproteome nuclear subfractionation kit (Qiagen).
Immunoprecipitation and Western Blotting.

Signaling studies were

performed on suspended cells that were plated on bacteriological dishes
precoated with 1% heat inactivated bovine serum albumin to prevent adhesion.
To study cellular signaling following 24 hours of pressure treatment, cells were
grown on collagen I pre-coated tissue culture dishes. The cells were exposed to
ambient or increased pressure for the desired time point and collected by
centrifugation. A lysis buffer containing 50mM Tris pH 7.4, 150 mM NaCl, 1%
Triton X-100, 10% glycerol, 1% deoxycholic acid, 0.1% SDS, 1mM EDTA, 1mM
EGTA, 1mM PMSF, 1mM sodium vanadate, 50 mM NaF, 10mM sodium

15
pyrophosphate, 2 µg/mL aprotinin, and 2 µg/mL leupeptin was then used at 4°C.
Total protein concentrations of the cell lysates were found using a bicinchoninic
acid (BCA) protein assay kit (Pierce, Rockford, IL). For co-immunoprecipitation
studies, 400µg of protein for each sample was incubated with its appropriate
antibody for 1 hour, after which time agarose beads (Santa Cruz Biotechnology,
Santa Cruz, CA) were added overnight. Proteins were resolved by sodium
dodecyl sulfate polyacrylamide gel electrophoresis and transferred to a Hybound
nitrocellulose membrane (Amersham Pharmacia Biotech). Mouse monoclonal
antibodies to total paxillin, p130cas, Crk, total Rac (BD Transduction lab, San
Diego, CA), GAPDH (Biodesign International, Saco, MN), actin (Sigma Aldrich),
HA (Covance, Berkley, CA), cyclin D1, phospho-IkB, and myc (Cell Signaling,
Beverly, MA), as well as rabbit polyclonal antibodies for CARP-1, total IkB
(Sigma Aldrich), Histone H1 (Santa Cruz Biotechnology, Santa Cruz, CA),
phospho-paxillin (pY31 – Biosource, Camarillo, CA; pY118 – Cell Signaling),
phospho-FAK (Biosource), NF-kB p65 (Millipore, Billerica, MA), alpha-tubulin,
phospho-IKKα/β, NF-kB p50 and phospho-Rac (Cell Signaling) were used for
immunoprecipitation studies and/or protein detection along with the appropriate
horseradish peroxidase – conjungated secondary antibodies. Antibodies are
provided in an alphabetical listing in Table 2. Proteins were visualized by ECLPlus techniques (Amersham Pharmacia Biotech) and imaged and quantitated
using a Kodak Phosphoimager (Perkin Elmer, Boston, MA). All blots were
studied within the linear range of exposure.
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NF-kB p50 and p65 Transcription Factor Activity. NF-kB p50 and p65
DNA binding activity was evaluated in nuclear lysates added to multi-well plates
coated with the double stranded DNA consensus sequence by an ELISA based
NF-kB p50 or p65 Transcription Factor Assay Kit (Cayman Chemical, Ann Arbor,
MI).
In Vivo Splenic Injections.

Luciferase tagged CT-26 murine colon

cancer cells were exposed to ambient or increased pressure for 30 minutes.
Following pressure exposure, cells were collected by centrifugation and washed
with sterile phosphate buffered saline solution. Balb/c mice were anesthetized
with 60 mg/kg of intraperitoneal sodium pentobarbital and a small incision was
made just above the spleen. Using a 30 gauge needle, one million cells were
slowly injected into the spleen. The cavity was aspirated and closed using a
suture or small animal wound clip.
For long term survival studies following splenic injections, mice were
euthanized when visible internal tumor burden reached a maximum or when the
mice became scruffy, lethargic or unable to take in food or water, as determined
by DLAR personnel.
In Vivo Tail Vein Injection and Cardiac Puncture. CT-26 murine colon
cancer cells were labeled with CFSE for 30 minutes, collected by centrifugation
and washed with sterile phosphate buffered saline solution. 1 million cells were
injected into the tail vein of Balb/c mice. After 30 minutes, the mice were
euthanized and cells were collected by injection of a 30 gauge needle into the left
ventricle of the mouse. 1mL of heparin and 5 mL of red blood cell lysis buffer
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were added to prevent blood clotting. The cellular suspension was centrifuged
and the supernatant was discarded. The cellular pellet was used for further flow
cytometric studies.
For long term survival studies following tail vein injections, mice were
euthanized when visible internal tumor burden reached a maximum or when the
mice became scruffy, lethargic or unable to take in food or water, as determined
by DLAR personnel.
Bioluminescent Imaging of Metastasis. 10 days following splenic or tail
vein injections, mice were re-anesthetized with 60 mg/kg of sodium pentobarbital
and administered 150 mg/kg D-luciferin (BD Bioscience) intraperitoneally. After
10 minutes, mice were assessed for relative CT-26 luciferase bioluminescence
using a Kodak IS4000MM small animal imaging device over a 10 minute time
period. Exposure conditions that include time, aperture, stage position, binning,
and time after D-luciferin injection, were all held constant for each measurement.
Bioluminescence intensity images were pseudo-colored (pink least intense and
red most intense). All images were quantified using MetaMorph software
(Universal Imaging Corp). Average image intensity was quantified using a fixed
region of interest and calculated values were expressed as relative light units per
minute (RLU).
Active NF-kB, Cyclin D1 and IkB Immunohistochemistry in Human
Tumors. Under IRB-approved protocol, archived colon, lung and head and neck
malignant tumors were sectioned, deparaffinized, steamed at 95°C with citrate
antigen retrieval buffer (DAKO, Carpinteria, CA), rinsed with PBS and fixed with
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3% hydrogen peroxide. Non-specific staining was prevented by adding horse
serum (Vector Laboratories, Burlingame, CA). The slides were rinsed and
primary antibody to active NF-kB (Invitrogen), cyclin D1, or IkB was added at
room temperature. After PBS-washing, slides were incubated with the
biotinylated

secondary

antibody,

streptavidin-peroxidase

and

amino-ethyl

carbazol chromogen (VectaStain Universal Rapid Kit, Vector). Staining intensity
was monitored to prevent overstaining. Slides were hematoxylin-counterstained
and coverslipped using Geltol (ThermoShandon, Fisher Scientific, Hanover Park,
IL).
A reviewer blinded to the study assigned scores from 0 (no
immunostaining) to 4 (maximal immunostaining intensity) to the three areas
under review; tumor center, tumor periphery and adjacent non-malignant tissue.
Areas were determined based on proximity to non-malignant tissue, cell
morphology and density. All areas of the slide that were able to be evaluated
were evaluated.
Discernable mitotic figures were also counted in each area of the tumor
periphery and center. Mitotic figures were also counted separately in tumor areas
defined subjectively by a blinded reviewer as highly immunoreactive for active
NF-kB or less immunoreactive for active NF-kB. All areas of the slide were
counted for these studies.
Statistical Analysis. SigmaStat (SPSS Inc., Chicago, IL) was utilized for
statistical analysis. Results were expressed as mean ± standard error.
Differences between two groups were analyzed using Student’s t-test and
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differences in immunostaining intensities were evaluated by chi-squared.
Statistical significance was set at p<0.05.
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Table 1. Inhibitors
Inhibitor

Target

Concentration

Manufacture

(Adhesion, Proliferation)

Catalog
Number

PP2

Src

65nM, 30nM

EMD Chemicals

529573

NSC23766

Rac1

50uM, 30uM

EMD Chemicals

553502

Akt Inh. IV

Akt

1uM

EMD Chemicals

124011

SN50

NF-kB

12uM

EMD Chemicals

481480

Serine 276
Inhibitory
peptide

NF-kB

25uM

Imgenex

IMG-2001

TCH-021

NF-kB

5uM

Dr. Jetze Tepe

N/A

Calphostin C

PKC

100nM

EMD Chemicals

UCN1028c

Go6976

PKC α/β

6nM

EMD Chemicals

365250

3-(1-(3Imidazol-1ylpropyl)1H-indol3-yl)-4anilino-1Hpyrrole-2,5dione

PKC β

15nM

EMD Chemicals

539654

PKC-ε
Inh.
Peptide

PKC ε

10nM

EMD Chemicals

539522

IKK-2 Inh.

IKK

10mM

EMD Chemicals

401481

IKK-3 Inh.

IKK

40nM

EMD Chemicals

401488

IKK
PhosphoInhibitor

IKK

90nM

EMD Chemicals

401489
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Table 2. Antibodies
Antibody

Source

Manufacture

Actin

Mouse

Sigma Aldrich

A3853

CARP-1

Rabbit

Sigma Aldrich

HPA007856

Crk

Mouse

BD Biosciences

610035

Cyclin D1

Mouse

Cell Signaling

2922

FAK (phospho) Rabbit

Biosource

700255

GAPDH

Mouse

Biodesign Intl.

H86045M

HA

Mouse

Covance

MMS-101R

Histone H1

Rabbit

Santa Cruz

SC-10806

IkB (phospho)

Mouse

Cell Signaling

9246

IkB (total)

Rabbit

Sigma Aldrich

I0505

IKK α/β
(phospho)

Rabbit

Cell Signaling

2681

Myc

Mouse

Cell Signaling

2278

NF-kB (p50)

Rabbit

Cell Signaling

3035

NF-kB (p65)

Rabbit

Millipore

AB1604

p130cas

Mouse

BD Biosciences

610271

Paxillin (total)

Mouse

BD Biosciences

610568

Paxillin
(phosphoY31)

Rabbit

Biosource

44720G

Paxillin
(phosphoY118) Rabbit

Cell Signaling

2541

Rac1 (total)

BD Biosciences

610650

Mouse

Catalog
Number
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CHAPTER 3
CARP-1 Modulation of Pressure-Induced Cancer Cell Adhesion
Malignant tumor cells in cancer patients undergoing surgical resection
may be susceptible to extracellular forces such as increased pressure and shear
stress during tumor manipulation or during passage through the venous and
lymphatic system during dissemination. Tumor cells shed into a body cavity may
also be exposed to pressure, shear, and turbulence during laparoscopic
insufflation or irrigation, whereas intraabdominal pressure increases substantially
for 2 to 3 days after surgery because of bowel edema and third spacing [1,5].
Previous studies suggest that increases in extracellular pressure, similar in
magnitude to those observed in vivo in some surgical patients, stimulate the
adhesion of colon cancer cells by a focal adhesion kinase (FAK)-dependent
mechanism, but the other mediators of this pathway are poorly understood [7].
Interstitial fluid pressure in patients with invasive ductal carcinoma is
increased compared with normal breast parenchyma and other malignant and
nonmalignant conditions [18,19] by as much as 29 mmHg. We hypothesized that
the adhesion of breast cancer cells might therefore be stimulated by extracellular
pressure in a manner similar to that observed in colon cancer cells.
CARP-1/CCAR1 is a novel protein that has been implicated in cell-cycle
and apoptosis regulation [39,40]. CARP-1 is a perinuclear/cytoplasmic
transducer of apoptosis signaling that binds with stratifin/14-3-3 sigma. Depletion
of CARP-1 inhibits apoptosis caused by agents such as adriamycin. Conversely,
overexpression of CARP-1 increases apoptosis and reduces expression of
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various cell-cycle regulators including c-myc and cyclin B. CARP-1 is expressed
in a variety of cell types including human breast and colon cancer cells. Because
CARP-1 regulates diverse intracellular signaling pathways, we hypothesized that
CARP-1 levels influence pressure-stimulated cancer cell adhesion by modulating
mediators of the pathways of cell adhesion and motility such as FAK [39].
We tested these hypotheses by studying MDA-MB-468 breast cancer cells
in which CARP-1 expression was down-regulated or enhanced by stable
expression of antisense or full-length complementary DNA (cDNA), respectively.
We performed adhesion assays under conditions of ambient or 15 mmHg
increased extracellular pressure and assessed CARP-1 levels, CARP-1dependent attenuation of FAK activation, and CARP-1 regulation of FAK by
western blotting.
We

previously

performed

various

experiments

involving

different

pressures and different time points and found that a 30-minute exposure to
increased pressure was sufficient to both activate intracellular signals and
enhance adhesion in colonic adenocarcinoma and other cancer cells [7]. We
chose to replicate these conditions while evaluating CARP-1 in MDA-MB-468
cells, both for consistency with our previous signal transduction work and
because breast cancer cells are likely to experience a range of increased
pressures up to 30 mmHg; 15 mmHg pressure increases therefore seem relevant
to breast cancer patho-physiology.
We first sought to determine whether adhesion of MDA-MB-468 breast
cancer cells increases in response to pressure because pressure effects on
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breast cancer cells had not previously been shown. Single cell suspensions of
several subclones of MDA-MB-468 breast cancer cells were allowed to adhere to
type-I collagen for 30 minutes under ambient, 15 mmHg, or 30 mmHg increased
pressure conditions before washing away nonadherent cells. Because the subclones yielded similar results, data were pooled for analysis.

MDA-MD-468

adhesion was increased by 25% ± 6% in response to 15 mmHg and 46% ± 9% in
response to 30 mmHg increased pressure (Figure 1, n=3; p,0.05).
Because MDA-MB-468 breast cancer cells are known to express CARP-1
and because FAK activation has previously been shown to mediate the effects of
pressure on cancer cell adhesion, we sought initially to determine whether
manipulating CARP-1 levels alters basal FAK activation. Cells were either
untreated (wild type) or treated with retroviruses expressing wild-type CARP-1 for
24 or 48 hours, followed by western blot analysis for expression of activated (pFAK) and native FAK proteins. FAK-397 phosphorylation was dramatically
inhibited by CARP-1 overexpression (Figure 2, n=3; p<0.05).
Because pressure-stimulated MDA-MB-468 breast cancer cells adhesion
and CARP-1 appeared to modulate FAK signaling, we created stable cell lines
that overexpress CARP-1 or display decreased CARP-1 expression to
investigate whether CARP-1 modulation would alter the adhesive response to
pressure. We have previously characterized MDA-MB-468 subclones, stably
transfected with antisense to CARP-1, which express approximately 50% less
CARP-1 protein compared with the parental line. We chose 2 such subclones
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Cell Adhesion / Control

1.8
1.5

Control
Pressure

*

*

1.2
0.9
0.6
0.3
0.0
Wild Type
MDA-MB-468
15 mmHg

Wild Type
MDA-MB-468
30 mmHg

Figure 1. Effects of pressure on wild-type and vector-transfected cell
adhesion. Adhesion to type I collagen under ambient pressure conditions (open
bars) was compared with adhesion under conditions of 15 mmHg increased
pressure and again under conditions of 30 mmHg increased pressure (shaded
bars) for 30 minutes. At least 20 high-power fields were counted in each dish,
and 3 separate dishes were studied in each experiment. Adhesion data for each
cell line were normalized to their respective ambient pressure controls before
pooling data from 2 separate experiments with similar results (*P<0.05).
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Figure 2. Overexpression of CARP-1 leads to inhibition of FAK activity.
FAK-397 phosphorylation was compared in wild-type parental cells (lane 1), cells
that were transduced with viruses encoding CARP-1 (lanes 3 and 4, for a period
of 24 and 48 hours, respectively). Blots were stripped and reprobed for total FAK
protein as a loading control. FAK-397 phosphorylation was dramatically inhibited
by CARP-1 overexpression. Representative western blots are shown from 1 of 3
similar studies.
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and compared their adhesive response to pressure with 2 antisense-transfected
subclones with normal CARP-1 expression.
Despite successful reduction of CARP-1, both cell lines expressing
reduced CARP-1 continued to display pressure stimulated adhesion (Figure 3,
n=16; p<0.05). Pressure stimulated adhesion in the antisense-transfected cells
that did not express reduced CARP-1 was similar to both the parental line and
the CARP-1 reduced cells.
Because reducing CARP-1 did not appear to modulate pressure
stimulated adhesion, we performed similar studies after stably overexpressing
CARP-1 (Figure 4, n=3; p<0.05). Adhesive responses to increased extracellular
pressures in CARP-1 overexpressing cells were also similar to those observed in
matched subclones from the same transfections that did not express CARP-1
(Figure 5, n=16; p<0.05).
The regulation of cancer cell adhesion is an important phenomenon that
may affect cancer metastasis in the perioperative period. Cell adhesion may be
influenced by FAK signaling, and pressure stimulated adhesion is known to be
mediated by FAK activation, but the mechanism by which this FAK signaling is
activated by extracellular pressure is poorly understood [41]. Our data suggests
that breast cancer cells display an increased adhesive response to extracellular
pressure similar to that which we have previously described in colon cancer cells.
Thus, the effect of extracellular pressure on cancer cell adhesion is not limited to
colon cancers [41]. CARP-1 does modulate basal FAK signaling, but changes in
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Control
Pressure

Cell Adhesion / Control

1.6
1.4

*

1.2

*

*

1.0

*

*

0.8
0.6
0.4
0.2
0.0
Vector

AS-1

AS-4

Control

AS-9

AS-10

Reduced CARP-1

Figure 3.
Reduction of CARP-1 does not alter pressure-stimulated
adhesion. Cell adhesion under ambient pressure conditions (open bars), was
compared with adhesion under 15 mmHg increased pressure conditions (shaded
bars) for an empty vector, as well as 2 MD-MBA-468 subclones that did not
display CARP-1 reduction (clone 1.6 subline 1 and clone 1.6 subline 4; AS-1 and
AS-4, respectively) and 2 subclones that displayed approximately 50% CARP-1
reduction (clone 1.6 subline 9 and clone 1.6 subline 10; AS-9 and AS-10,
respectively). Each subclone displayed increased adhesion in response to
extracellular pressure, independently of modulation of CARP-1 expression. At
least 20 high power fields were counted iin each dish, and 2 separate dishes
were studied in each experiment. Adhesion data for each cell line were
normalized to their respective ambient pressure controls before pooling data from
at least 8 separate experiments with similar results (*P<0.05).
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Figure 4. Overexpression of CARP-1. Stable overexpression of CARP-1 is
shown in MDA-MB-468 CARP-1 subline 4 in lane 1 compared with the parental
MDA-MB-468 line in lane 2. This figure depicts 1 of 3 similar western blots
probed for the overexpressed myc-tagged transfectant with anti-myc antibody, for
native CARP-1 itself with CARP-1 (α-2) antibody, and with α-tubulin as a protein
loading control.
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Cell Adhesion / Control

1.6

Control
Pressure

*

1.2

*

0.8

0.4
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Only

MDA-MB-468
Subline 4

Figure 5. Overexpression of CARP-1 does not alter pressure-stimulated
adhesion. Cell adhesion under ambient pressure conditions (open bars) was
compared with adhesion under 15 mmHg increased pressure conditions (shaded
bars) for the MDA-MB-468 CARP-1 subline 4, which overexpresses CARP-1 and
for MDA-MB-468 cells transfected with the empty vector alone. Each subclone
displayed increased adhesion in response to extracellular pressure,
independently of modulation of CARP-1 expression. At least 20 high power
fields were counted in each dish, and 3 separate dishes were studied in each
experiment. Adhesion data for each cell line were normalized to their respective
ambient pressure controls before pooling data from 2 separate experiments with
similar results (*P<0.05).
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CARP-1 expression does not affect the adhesive response to pressure, which
suggests that CARP-1 is not involved in pressure stimulated adhesion.
Interstitial pressure is elevated in breast cancer patients undergoing
needle biopsy [18]. In fact, increases in interstitial pressure seem to be a
characteristic of rapidly growing breast cancers against their defining stroma. The
activation of the adhesion of cancer cells by endogenous pressure within the
tumor may affect the potential for metastasis both by increasing the incidence of
local wound recurrence in the perioperative period, a complication requiring
subsequent reoperation and mastectomy, or by increasing the metastatic
potential of tumor cells as they pass through the lymphatics during dissemination
even before surgical resection. Furthermore, when surgery is performed on
breast cancer patients, even more pressure is exerted, which may cause a direct
local effect specific to the perioperatiive period in which further pressure by
surgical manipulation might cause shed tumor cells to adhere more efficiently.
Thus, the pathway by which pressure stimulates adhesion may well be significant
for breast cancer cells in vivo. We have previously shown that pressure
stimulates colon cancer cell adhesion not only to purified matrix proteins but also
to endothelial cell monolayers [41] and to surgical wounds in vivo [21].
Focal adhesion kinase (FAK) is a protein tyrosine kinase that is often
overexpressed in cancer cells [41]. It is recruited to focal adhesions on the
clustering of integrins through molecules such as talin or paxillin. FAK tyrosine
397 is of particular interest because it rapidly undergoes autophosphorylation on
cell adhesion to extracellular matrix proteins. This leaves a docking site for the
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Src homology 2 domains of the Src family protein kinases that bind and further
activate FAK, leading to association with PI3 kinase and activation of the MAP
kinase cascade [42,43,44]. Previous studies have shown that pressure
stimulates cell adhesion via FAK autophosphorylation of tyrosine 397.
Conversely, blocking FAK signaling by transfection of a dominant negative FAK
construct or reducing FAK by specific siRNA each prevent pressure stimulated
adhesion in colon cancer cells [45,46]. Similar FAK signaling pathways seem to
mediate pressure effects in various cell types. Our study extends these
observations to breast cancer cells. Although FAK activation has not been
specifically shown to mediate pressure stimulated adhesion in breast cancer cells
in these studies, FAK may be similarly involved. Our results indicate that
although CARP-1 does inhibit basal FAK tyrosine 397 phosphorylation, CARP-1
overexpression does not appear to block the stimulation of FAK tyrosine 397
phosphorylation by extracellular pressure or at least one downstream
consequence; increased adhesion. This does not exclude the possibility that
CARP-1 effects on FAK activation could still be important to other aspects of FAK
signaling.
We have previously studied the effects of pressure on colon cancer cell
apoptosis and anoikis [31]. Thus, pressure mediated FAK signaling might have
other effects, with which CARP-1 might conceivably also interact. Such other
potential effects of pressure in these cells await further study. CARP-1 is involved
in apoptosis signaling pathways through interactions with the cytoplasmic protein
14-3-3 [39]. Overexpression of CARP-1 inhibits cell growth regulatory proteins
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such as c-myc. When CARP-1 was depleted, cell-cycle arrest and apoptosis
signaling were altered [39,40]. Because CARP-1 modulates FAK signaling and
FAK signaling is required for pressure stimulated adhesion, one would therefore
similarly expect that modulation of CARP-1 would alter pressure stimulated
adhesion. However, neither long term depletion nor overexpression of CARP-1
impeded pressure stimulated adhesion in breast cancer cells. Furthermore, no
significant changes in CARP-1 levels were noted after short-term exposure to 15
mmHg increased pressure.
Our initial studies show that CARP-1 does modulate FAK activation in
transient overexpression studies and raised the question of whether such a
modulation might mediate pressure stimulated adhesion. The apparent
dichotomy between the modulation of FAK in transient CARP-1 overexpression
and the lack of effect of stable CARP-1 overexpression or underexpression might
reflect adaptive processes to the chronic stable transfection. These might include
compensatory modulation of other proteins that might interact with CARP-1, FAK
or other proteins in the signal cascade. Indeed, database analyses recently
revealed the presence of human deleted in breast cancer (DBC)-1 protein, which
has significant homology to human CARP-1. Although CARP-1 and DBC-1 are
encoded by separate genes located on chromosome 10 and 8, respectively,
whether they possess overlapping or distinct functional domains and the extent
to which DBC-1 may regulate signaling for pressure induced cell adhesion
remain to be elucidated [39,40]. The characterization of such adaptations would
be an interesting study in its own right, but our own results suffice to address our
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initial hypothesis about CARP-1 because the stable transfection results strongly
suggest that CARP-1 itself does not seem to modulate pressure stimulated
adhesion. Alternatively, because CARP-1 modulates many other signal proteins
besides FAK, the downstream effectors of CARP-1 may interact with the
pressure pathway in other compensatory ways, co-modulating FAK signaling or
reconstituting the pressure activated pathway downstream of FAK. Better
understanding of how breast cancer cell pressure stimulated adhesion is
reconstituted despite CARP-1 modulation therefore awaits delineation of the
precise mechanism by which FAK itself modulates pressure stimulated adhesion
in the future.
The results of this study do not exclude the possibility that CARP-1 may
modulate other downstream consequences of FAK signaling. We studied the
effects of inside out signaling in which intracellular signaling events triggered by
increased extracellular pressure regulate integrin ligand binding function.
However, FAK has been most frequently described as active in outside in
signaling after cell adhesion, in which the occupancy of integrins by matrix
ligands from outside the cell initiates signaling within the cell on ligand binding
that then leads to downstream cellular consequences [41,46]. These results,
therefore, do not exclude the possibility that CARP-1 modulation of FAK
activation may influence outside-in signaling downstream of FAK, which is
beyond the scope of our CARP-1/FAK study.
For the first time, we have shown that breast cancer cells do display
pressure

stimulated

adhesion.

This

information

may

be

important for
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perioperative management to reduce local wound recurrence as well as for our
ultimate understanding of the biology of these neoplasms. Because pressure
also stimulates cancer cell proliferation [31], the proliferation of breast cancer
cells within a constraining stroma may also be stimulated by extracellular
pressure, causing a positive feedback cycle in which more rapidly proliferating
tumors generate more pressure, which may cause increased proliferation.
CARP-1 does inhibit FAK and could contribute to modulation of some of the
signaling actions of this important kinase. Although the mechanisms by which
breast cancer cells escape from CARP-1 modulation to continue to display
pressure stimulated adhesion are unclear, our data suggests that CARP-1
modulation may not be an attractive target for interventions designed to interfere
with this potentially deleterious pressure activated pathway.
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CHAPTER 4
Role of Paxillin in Pressure-Induced Colon Cancer Cell Signaling
Paxillin is a 68 kDa focal adhesion associated protein that facilitates
protein – protein interactions, focal adhesion assembly and functions in cell
signaling downstream of integrins [47]. These events influence diverse cellular
behaviors, including cell migration, proliferation, survival and apoptosis. In some
cases, paxillin functions as a structural protein that links other proteins and
facilitates formation of focal adhesions [26]. However, in other instances, kinases
may phosphorylate paxillin directly and alter its binding affinity [24]. Paxillin
localizes to focal adhesions and has been shown to interact directly with the α5
and α9 subunit of β1 – integrin [48,49,50] and provide a platform for tyrosine
kinases including FAK and Src that can become activated in response to
adhesion or growth factor stimulation [26,51,52,53]. Paxillin phosphorylation may
also regulate the recruitment of downstream molecules such as Crk that can
further lead to activation of p130Cas [29,47]. In addition, negative regulators of
these pathways, including Csk and PTP-PEST bind directly to paxillin.
Previous studies from our laboratory have shown that paxillin is required
for extracellular pressure to increase cancer cell adhesion, since paxillin
reduction by siRNA blocks the effect and paxillin overexpression seems to
reproduce

it.

Increased

extracellular

pressure

also

stimulates

paxillin

phosphorylation at tyrosines 31 and 118 [25,54]. However, it has not been clear
whether paxillin acts simply as an adaptor protein or whether paxillin
phosphorylation is necessary for the effects of extracellular pressure on cancer
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cell adhesion. This is important because understanding how paxillin acts may
ultimately facilitate the design of therapeutic interventions to reduce cancer cell
adhesion and metastasis.
We therefore hypothesized that paxillin phosphorylation is important to the
regulation of cancer cell adhesion, and sought to test this hypothesis using
paxillin phosphorylation single mutants that are unable to be phosphorylated at
tyrosine 31, 118 or 181, a Y31Y118 double mutant and a Y31Y118Y181 triple
mutant. We transfected these constructs into human SW620 colon cancer cells
and examined their effects on pressure stimulated cancer cell adhesion. We then
determined the effects of increased pressure and transfection with nonphosphorylatable paxillin mutants on the potential paxillin associated molecules
Crk, Cas and Rac1 to further delineate signaling events downstream of paxillin.
Next, we examined the association of paxillin with α-actinin a molecules that is
known to be involved in pressure – stimulated cancer cell adhesion [55], by
reducing α-actinin levels and evaluating paxillin phosphorylation. Finally, we
explored these signaling events in primary human colon cancer cells to confirm
that our observations are not limited to a single cell line.
We have previously reported that increased extracellular pressure
promotes paxillin phosphorylation in head and neck cancer cells [54]. However,
we had yet to identify whether this phosphorylation is important to pressure stimulated cancer cell adhesion. The cells transfected with single plasmid
phosphorylation mutants all displayed increased adhesion in response to
increased pressure. However, the cells transfected with the triple mutant did not
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exhibit an increase in adhesion in response to pressure elevation (Figure 6A,
n=5; p<0.05).
Tyrosine 31 and tyrosine 118 on paxillin are phosphorylated by FAK in
response to various cellular events, including adhesion [52]. Since FAK is
involved in pressure - stimulated cancer cell adhesion, we next sought to block
these two tyrosine phosphorylation sites specifically. We transfected cells with a
myc-tagged plasmid mutant that is unable to be phosphorylated at both tyrosines
31 and 118 and similarly evaluated basal and pressure stimulated adhesion.
Transfection with a construct unable to be phosphorylated at these two tyrosine
phosphorylation sites was sufficient to block pressure stimulated adhesion
(Figure 6B, n=4; p<0.05).
In some other systems, paxillin phosphorylation at tyrosine 31 and
tyrosine 118 creates a docking site for the adaptor protein Crk [27,52,56,57]. We
therefore sought to determine whether Crk is also involved in pressure stimulated
adhesion. Crk was reduced in SW620 cells approximately 74% by siRNA
treatment and the cells were exposed in ambient or increased pressure (Figure
7A). When Crk was reduced, pressure did not stimulate cell adhesion (Figure 7B,
n=4; p<0.05).
To evaluate the potential association between paxillin and Crk under
pressure, we performed co-immunoprecipitation studies using SW620 cells
exposed to ambient or increased pressure. Indeed, pressure increased the
association of paxillin with Crk by 36 ± 8% compared to ambient pressure
controls (Figure 7C, n=6; p<0.05). We therefore, next evaluated the association
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Figure 6. Effect of paxillin plasmid phosphorylation mutants on pressurestimulated colon cancer cell adhesion. (A) 15mmHg increased extracellular
pressure (shaded bars) stimulated SW620 cell adhesion to type I collagen in
cells transfected with an HA-tagged Y31, Y118 and Y181 paxillin plasmid
phosphorylation mutant, similar to that observed in wild type transfected cells.
However, cells transfected with a Y31Y118Y181 plasmid phosphorylation mutant
did not display increased adhesion in response to elevated pressure (n=5;
p<0.05). (B) SW620 cells transfected with a Y31Y118 paxillin plasmid
phosphorylation mutant did not display increased adhesion to type I collagen in
response to elevated pressure (shaded bars) relative to ambient pressure
controls (open bars) (n=4; p<0.05).

40
A.

B.

1.6

Control
Pressure

Cell Adhesion / Control

Crk Expression

1.5

1.0

0.5

*

0.0

1.2

*

n.s.

0.8

0.4

0.0

siNT

siCrk

siNT

siCrk

Fold increase in Crk Co-IP with paxillin

C.

1 .5
C o n tro l
P re s s u re

*

1 .0

0 .5

0 .0

A m b ie n t

15 m m H g

Figure 7. Crk is necessary for pressure stimulated colon cancer cell
adhesion and Crk interacts with paxillin. (A) Typical reduction of Crk in
SW620 cells transfected with Crk-specific siRNA. GAPDH was used as a
loading control and Crk protein expression was normalized against non-targeting
siRNA controls (n=4; p<0.05). (B) Cells transfected with a non-targeting siRNA
control exhibited increased adhesion in response to 15 mmHg elevated pressure
(shaded bars). In contrast, cells transfected with Crk-specific siRNA did not
display increased adhesion in response to pressure (n=4; p<0.05). (C) Equal
protein samples from SW620 cells that were exposed to ambient (open bar) or
increased pressure (black bar) were immunoprecipitated for paxillin and probed
for Crk by western blot. Samples were normalized against ambient controls
(n=6; p<0.05). Paxillin-Crk association was increased in pressure-treated cells.
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of Crk with paxillin in SW620 cells transfected with the paxillin single tyrosine
mutants and the tyrosine double mutant by similar co-immunoprecipitation
analysis. Paxillin-Crk interaction was increased under pressure by 34 ± 9%, 27 ±
4% and 32 ± 6% in the Y31, Y118 and Y181 transfected cells, respectively
(Figure 8A, n=6; p<0.05). However, the association between paxillin and Crk was
not significantly increased in the cells transfected with the Y31Y118 double
mutant (Figure 8B, n=5; p<0.05).
To further validate these results, we assessed the interaction of paxillin
and Crk under ambient and increased pressure conditions in primary human
colon cancer cells isolated from 6 surgically resected specimens. Primary colon
cancer cells yielded results similar to SW620 cells. Pressure increased the
interaction of paxillin and Crk in these human cancer cells by 38 ± 4% (Figure 9,
p<0.05).
Cas is a highly phosphorylated protein that may associate with Crk upon
activation of Cas by Src [30,58,59]. We therefore investigated whether Cas is
necessary for pressure - stimulated adhesion. We used siRNA to reduce Cas by
approximately 62% in SW620 cells and exposed the cells to ambient or
increased pressure (Figure 10A, n=3; p<0.05). Pressure - stimulated adhesion
was abolished in these cells when siRNA was used to reduce Cas (Figure 10B,
n=3; p<0.05). To determine if SW620 cells can be rescued from siRNA
treatment, we transfected the cells with Cas specific siRNA in the presence of a
Cas rescue plasmid or vector control. Cells transfected with Cas specific siRNA
and Cas rescue plamid displayed increased adhesion in response to pressure,
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Figure 8. SW620 cells treated with paxillin point mutants display increased
co-immunoprecipitation under pressure, double mutant treated cells do
not. (A) Equal protein samples from SW620 cells that were transfected with a
HA-tagged Y31, Y118 or Y181 paxillin plasmid phosphorylation mutants and
exposed to ambient or increased pressure were utilized for coimmunoprecipitation studies. Crk co-immunoprecipitation with each mutant was
significantly increased with elevated pressure (black bars) relative to ambient
pressure controls (white bars) (n=6; p<0.05). (B) Co-immunoprecipitation
studies were performed on equal protein samples from SW620 cells that had
been transfected with a myc-tagged Y31Y118 paxillin plasmid phosphorylation
mutant and exposed to ambient or 15 mmHg increased pressure. Crk coimmunoprecipitation with myc tagged paxillin was not increased in response to
elevated pressure (n=5; p<0.05).
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Figure 9. Pressure increases co-immunoprecipitation between paxillin and
Crk in surgically resected human colon cancer cells. Primary human colon
cancer cells isolated from surgically resected specimens were exposed to
ambient or 15 mmHg increased pressure. Protein samples were used for coimmunoprecipitation studies and analyzed by western blot to evaluate the
association of paxillin and Crk. Pressure increased paxillin-Crk association in
primary colon cancer cells from six patients similarly to our observations in
SW620 cells. (p<0.05).
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Figure 10. Cas is necessary for pressure-simulated adhesion. (A) Typical
reduction of Cas in SW620 cells transfected with Cas siRNA. GAPDH was used
as a loading control and Cas protein expression was normalized against nontargeting siRNA controls (n=3; p<0.05). (B) 15mmHg increased pressure (black
bars) stimulated the adhesion of SW620 colon cancer cells that had been
transfected with a non-target siRNA control. However, cells transfected with
Cas-specific siRNA did not increase adhesion in response to increased pressure
(n=3; p<0.05).
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however, cells transfected with Cas siRNA and vector control did not increase
adhesion in response to pressure (Figure 11, n=5; p<.05).
Since Crk and Cas may interact [60], we compared Crk-Cas interaction
under

conditions

of

ambient

and

elevated

pressure

using

co-

immunoprecipitation. Elevated pressure increases the association of Crk and
Cas by 38 ± 7% (Figure 12, n=6, p<0.05).
We further evaluated whether Cas-paxillin association also changes in
response to increased extracellular pressure. Cas did co-precipitate with paxillin
under ambient pressure conditions, and the association increased 36 ± 5% under
increased pressure conditions (Figure 13A, n=4; p<0.05).
We performed further studies to examine association between Cas and
paxillin in cells transfected with the paxillin single and double plasmid tyrosine
mutants. We found an increase of 30±9%, 24±5% and 32±6% between paxillin
and Cas under increased pressure conditions in the cells transfected with the
tyrosine 31, 118 and 181 plasmid mutants, respectively (data not shown; n=6;
p<0.05). In contrast, the cells transfected with the double tyrosine mutant
displayed no increase in association between paxillin and Cas after exposure to
increased pressure (Figure 13B, n=5; p<0.05).
Activated Cas may phosphorylate and activate members of the small
GTPase family, such as Rac1, that can in turn influence diverse cellular events
including migration, motility and adhesion [61,62]. We therefore treated SW620
cells with NSC23766, an inhibitor of the small GTPase Rac1 and reduced Rac1
activation by approximately 88% (Figure 14A, n=5; p<0.05). Pressure –
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Figure 11. Treatment with Cas rescue plasmid recovers the effect of
increased pressure on adhesion in the presence of Cas siRNA. Cotransfection of SW620 cells with Cas specific siRNA with a plasmid rescue
construct containing a rat Cas construct resulted in an increased adhesion in
response to pressure similar to non-targeting controls. Pressure had no effect in
cells co-transfected with Cas-specific siRNA and the empty vector control (n=5;
p<0.05).
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Figure 12. Cas and Crk co-immunoprecipitation increases under pressure.
Co-immunoprecipitation studies were performed using equal protein samples
from SW620 cells that had been exposed to ambient or increased pressure. The
samples were immunoprecipitated for Crk, probed for Cas by western blot and
normalized against total Crk. Pressure stimulated Crk-Cas association. (n=6;
p<.05)

48

Fold increase in Cas Co-IP with paxillin

A.

1.5
Control
Pressure

*

1.0

0.5

0.0

Am bient

15 m m Hg

Fold increase in Cas Co-IP with Paxillin

B.

1.5

Control
Pressure

*
1.0

0.5

0.0
WT

Y31Y118

Figure 13. Co-immunoprecipitation of Cas and paxillin increases with
pressure, however, effect is abolished following treatment with paxillin
Y31Y118 mutant. (A) SW620 cells were exposed to ambient or increased
pressure. Equal protein samples were subjected to co-immunoprecipitation.
Paxillin was immunoprecipitated and Cas was probed for by western blot.
Pressure stimulated paxillin-Cas association. (n=4, p<0.05). (B) Y31Y118
paxillin plasmid phosphorylation mutant was transfected into SW620 cells that
were then exposed to ambient or increased pressure. Protein samples were
immunoprecipitated for myc-tagged paxillin and cas protein levels were
evaluated by western blot. Pressure did not stimulate paxillin-cas association in
these cells. (n=5; p<.05).
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stimulated adhesion was abolished in cells treated with this inhibitor (Figure 14B,
n=5; p<0.05). Next, we sought to determine if Rac1 was activated in response to
elevated pressure. We performed a Rac1 pull down assay and found that Rac1
was activation was increased by 28% in response to pressure (Figure 15A, n=6;
p<.05).
We therefore further evaluated the phosphorylation of Rac1 in response to
increased extracellular pressure in SW620 cells transfected with either siRNA to
reduce paxillin or a control non-targeted siRNA sequence. In the control cells,
Rac1 phosphorylation was increased 38 ±4% under elevated pressure conditions
(Figure 15B, n=7; p<0.05). However, the cells that were treated with siRNA to
reduce paxillin showed no increase in phosphorylation in Rac1 in response to
pressure.
We have previously shown that pressure – stimulated cancer cell
adhesion requires FAK, Src and α-actinin. Therefore, we sought to evaluate the
effect of reducing these molecules on paxillin phosphorylation.
We treated SW620 cells with siRNA to FAK and examined paxillin
phosphorylation at Y31. The results indicated that paxillin Y31 phosphorylation is
increased under elevated pressure conditions in cells transfected with a nontarget siRNA control. In contrast, cells transfected with siFAK showed increased
basal phosphorylation, but no additional increase in phosphorylation in response
to elevated pressure (Figure 16, n=4; p<.05).
Next, we treated SW620 cells with PP2, a potent and specific inhibitor of
Src family kinases. We found that cells treated with a DMSO control displayed
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Figure 14. Rac1 is necessary for pressure-stimulated cancer cell adhesion.
(A) Typical reduction in phosphorylated (active) Rac1 using NSC23766, an
inhibitor of Rac1 activation. Phosphorylated Rac1 levels were normalized
against actin (n=5; p<.05). (B) Wild type SW620 cells displayed increased
adhesion in response to 15 mmHg increased pressure (shaded bars) relative to
ambient controls. However, this effect was not seen in cells treated with
NSC23766 (n=5; p<.05).
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Figure 15. Paxillin affects Rac1 phosphorylation. (A) A Rac1 pull down
assay was performed on SW620 cells that were exposed to ambient or increased
pressure. Pressure increased the activation of Rac1 by 28% relative to ambient
controls (n=6; p<.05). (B) SW620 cells transfected with a non-targeting siRNA
display increased phosphorylation of Rac1 in response to elevated pressure
(black bars) relative to ambient controls (white bars). Rac1 phosphorylation is
not increased in response to elevated pressure in SW620 cells transfected with
paxillin-specific siRNA (n=7; p<.05).
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Figure 16. FAK influences paxillin phosphorylation. Phosphorylation of
paxillin at tyrosine 31 increased under pressure in SW620 cells transfected with a
non-targeting control. This effect was abrogated in cells transfected with FAK
specific siRNA (n=4; p<0.05).
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increased paxillin Y31 phosphorylation in response to pressure, however, the
cells treated with PP2 had no increase in paxillin Y31 phosphorylation in
response to pressure (Figure 17, n=5; p<.05). This result was consistent with
similar observations in cells treated with Src specific siRNA that were probed for
paxillin phosphorylation at Y31 (data not shown).
Finally, we sought to determine if silencing α-actinin with siRNA would
affect paxillin Y31 phosphorylation. SW620 cells treated with a non-targeted
siRNA control displayed increased paxillin Y31 phosphorylation. However, cells
treated with siRNA to reduce α-actinin did not display increased phosphorylation
in response to elevated pressure (Figure 18, n=6; p<.05).
Because non – targeting siRNA can potentially affect some proteins, we
used scrambled siRNA sequences for several of the proteins examined to further
confirm our results. Cells transfected with scrambled siRNA for paxillin, Crk and
Cas all displayed increased adhesion in response to increased pressure similar
to non – targeted controls (Figure 19, n=4; p<.05).
Tumor cell adhesion in response to elevated pressure is a physiologically
relevant event, as metastasizing tumor cells are exposed to increased pressure
during passage through the circulatory or lymphatic systems or during and after
surgical procedures[63,64,65,66]. Elucidation of the intracellular signaling events
that influence this adhesion may uncover useful targets to inhibit metastasis.
Although previous preliminary studies had suggested that paxillin might be
required for extracellular pressure to stimulate cancer cell adhesion [25,54], it
was unclear whether paxillin was merely required for focal adhesion assembly
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Figure 17. Src influences paxillin phosphorylation. Treatment of SW620
cells with PP2 blocked increased phosphorylation of paxillin at tyrosine 31
compared to non-targeting transfected control cells (n=5; p<0.05).
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Figure 18. Alpha-actinin influences paxillin phosphorylation. Paxillin
phosphorylation in response to pressure was higher in SW620 cells transfected
with a control non-targeting siRNA but not in cells transfected with alpha-actinin-1
specific siRNA (n=6; p<0.05).
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Figure 19. Scrambled siRNA does not inhibit pressure-stimulated colon
cancer cell adhesion. Pressure elevations of 15 mmHg induced increases in
adhesion in SW620 cells transfected with scrambled siRNA sequences for
paxillin, Crk and Caswere similar to that in the non-targeting controls (n=5;
p<0.05).
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and linkage to the cytoskeleton or whether paxillin actually participated in a
dynamic signal pathway stimulated by increased extracellular pressure. Our
current data indicate that paxillin phosphorylation at tyrosines 31 and 118
together

is

necessary

for

pressure-induced

adhesion.

Furthermore,

phosphorylation at these two sites creates a binding site for the adaptor protein
Crk, leading to the recruitment of p130Cas and ultimately to the phosphorylation
of Rac1. Each of these steps seems required for extracellular pressure to
activate cancer cell adhesion.
Paxillin influences tumor biology in several ways. It participates in focal
adhesion assembly and links the focal adhesion complex to integrins and to the
cytoskeleton [26,67]. Paxillin expression is increased in metastatic head and
neck cancer and human osteosarcomas as well as aggressive breast cancer cell
lines [68,69,70].
In some instances, paxillin acts simply as a scaffolding protein that
functions to provide docking sites for a variety of structural and signaling
proteins. For example, in lymphoid cells, paxillin has been shown to bind directly
to the α4 integrin subunit [24]. Paxillin also provides a docking site for the protein
tyrosine kinases FAK and Src, which can in turn participate in diverse signaling
pathways [26]. A recent study by Geiger et al indicated that non-phosphorylated
paxillin is essential for the formation of fibrillar adhesions, and leads to enhanced
fibronectin fibrillogenesis in Porcine aortic endothelial cells [71]. In other
situations, paxillin phosphorylation is necessary for downstream signaling and
cellular functions. This necessity for phosphorylation is evident in a current study
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by Vallés et al that showed blocking paxillin tyrosine phosphorylation at sites 31
and 118 in NBT-II rat bladder carcinoma cells decreased motility on collagen by
approximately 50% [27]. In the current study we sought to determine the
relevance of paxillin tyrosine phosphorylation to pressure-stimulated colon
cancer cell adhesion.
Pressure appears to stimulate paxillin tyrosine phosphorylation at both
tyrosine 31 and tyrosine 118. Using plasmid phosphorylation mutants, we found
that tyrosine phosphorylation at sites 31 and 118 individually did not affect
pressure stimulated cancer cell adhesion. However, when both sites were
blocked simultaneously, the pressure effect was abolished. In contrast, point
mutation of tyrosine 181 seemed irrelevant. These results are consistent with
observations that paxillin tyrosine 31 and 118 phosphorylation is necessary for
adhesion, migration and cell spreading in other systems [47,72,73]. Recent data
has also implicated serine 273, as well as serine 188 and 190 phosphorylation as
influencing cell adhesion [74,75]. Although this result was obtained in epithelial
cells after adhesion had occurred, our present studies of paxillin tyrosine
phosphorylation certainly do not preclude the possibility that this serine
phosphorylation event may also occur in response to extracellular pressure.
Crk is a multifunctional adaptor protein that has been reported to bind to
many different intracellular proteins, depending upon the cell type and stimulus
studied. For instance, Crk can interact with phosphatidylinositol kinase (PI3
kinase), leading to the activation of the Akt signaling pathway [76], which also
influences colon cancer cell adhesion in response to extracellular pressure [77].
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Others have reported that Crk binds to the adaptor proteins DOCK180 and C3G
in a variety of cell types, and that these downstream proteins then can then
regulate cell migration or the mitogen activated protein kinase pathway,
respectively

[78,79].

The

results

presented

here

indicate

that

paxillin

phosphorylation within colon cancer cell lines or primary human colon cancer
cells in response to extracellular pressure facilitates paxillin-Crk binding, which is
also required for the ultimate stimulation of adhesion. The potential role of Crk in
modulating pressure stimulated cell adhesion has not previously been evaluated.
Our studies were designed to delineate the intracellular signaling in suspended
cells prior to adhesion that would then govern their subsequent adhesion; while
most other studies have evaluated Crk signaling in cells after adhesion had
occurred. Whether other proteins that interact with Crk may also participate in
pressure – induced signaling in cells prior to adhesion awaits further study.
p130Cas is also an adaptor that promotes protein – protein interactions
[30]. Cas interaction with other proteins modulates diverse cellular events
[58,60,80,81]. Cas modulates cell motility, and integrin – mediated cell adhesion
triggers Cas tyrosine phosphorylation that has been correlated with actin
cytoskeleton reorganization and focal adhesion formation [58]. However, the
ability of Cas to influence the binding affinity of suspended cells is less clear. Our
observations of Cas paralleled our studies with Crk. Paxillin phosphorylation in
response to pressure facilitates paxillin-Cas binding just as it does paxillin-Crk
binding. Cas is required for the stimulation of adhesion, however, the pressure
effect can be rescued from Cas siRNA treatment when a wild type Cas plasmid is
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transfected in conjunction with Cas specific siRNA. Although Cas has been
reported to associate with a wide variety of proteins, the present results suggest
a model in which paxillin, Cas, and Crk form a trimeric complex in response to
paxillin phosphorylation stimulated by pressure. This would be consistent with
similar observations in collagen stimulated NBT-II cells [82] as well as in
migrating FG-M carcinoma cells on vitronectin [60], although others have found
that Cas binds to the Tec/Btk family member Bmx in Cos-7 cells in response to
adhesion [83]. The differences between our observations and some of these
other reports may reflect differences in the cell types and stimuli studied.
Rac1 is a known binding partner of Cas, although Rac1 also binds to and
is activated by RhoG and aldosterone in other settings [84,85]. We therefore
hypothesized that the paxillin-Crk-Cas interaction might relevantly phosphorylate
and activate Rac1. Indeed, Rac1 is phosphorylated and activated in response to
extracellular pressure. Furthermore, reduction of paxillin by targeted siRNA
prevented increased Rac1 phosphorylation in response to elevated pressure.
Whether paxillin interacts directly with Rac1 or simply facilitates Cas
conformational changes that permit Cas phosphorylation of Rac1 awaits further
study.
Several investigators have reported that Rac1 is important in actin
polymerization, lamellipodial extension, and cell migration in various cell types,
but that Rac1 is not critical for adhesion itself [86,87,88,89]. Indeed, Rac1
inhibition by NSC23766 produced little effect on basal cell adhesion in our
studies. However, Rac1 inhibition completely prevented the stimulation of
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adhesion by extracellular pressure. Force-activated adhesion may be regulated
by a very different pathway than basal adhesion. We have previously reported
that reduction of some other signals in this pathway, such as α-actinin; also have
little effect on basal adhesion while nonetheless preventing the stimulation of
adhesion by pressure [55].
If paxillin phosphorylation is a critical event in pressure-stimulated
adhesion, what cellular events might trigger this phosphorylation in response to
extracellular pressure increases? A recent report by Chien et al suggests that
modifications of microtubule dynamics can increase paxillin phosphorylation,
although a mechanism for this effect was not explored [90]. FAK and Src are
focal adhesion proteins that are involved in intracellular signaling that regulates
proliferation, apoptosis, migration, and adhesion in both normal and tumor cells
[51]. FAK is phosphorylated at tyrosine 397 in response to various stimuli,
including adhesion itself and extracellular pressure prior to adhesion [41,91]. This
phosphorylation creates a binding site for Src where Src becomes activated and
further phosphorylates FAK. The FAK-Src complex is thought to control focal
adhesion turnover and target paxillin and Cas for phosphorylation [92].
Individually, FAK and Src have also been shown to be activated by various
stimuli, including PDGF, insulin and growth hormone, where they can directly
activate the MAP kinase pathway and promote cell migration [93,94,95]. Our
previous studies have shown that pressure – stimulated cancer cell adhesion is
dependent upon FAK and Src phosphorylation [41]. We therefore sought to
determine if either FAK or Src are required to for the stimulation of paxillin
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phosphorylation by elevated pressure. In our model, FAK reduction by targeted
siRNA stimulated basal paxillin phosphorylation at ambient pressure but
prevented further phosphorylation in response to pressure. The increase in
ambient pressure phosphorylation is consistent with reports that FAK null
fibroblasts display increased paxillin phosphorylation [96]. Although this increase
in basal paxillin phosphorylation in FAK null cells has not been explained, it may
reflect microtubular destabilization by FAK reduction, as has been reported in
neuronal cells as well as in mouse fibroblasts [97,98]. However, the blockade of
stimulation by pressure of paxillin phosphorylation in FAK-reduced cells suggests
a role for FAK in this effect. Src inhibition also prevented the stimulation of
paxillin phosphorylation by pressure, although without a notable effect on basal
ambient pressure phosphorylation, again suggesting that paxillin is probably
downstream of FAK and Src in the signal pathway by which suspended cancer
cells respond to extracellular pressure. Previous studies have suggested that
paxillin phosphorylation does increase in response to elevated pressure in cells
treated with FAK-specific siRNA or PP2 [25]. However, we obtained a greater
reduction in FAK levels (~70%) and treated with PP2 for a longer amount of time
(4 hours) which could account for this difference.
α-Actinin is an actin crosslinking protein that interacts with multiple focal
adhesion proteins and is able to bind to the cytoplasmic tail of β1 integrin. αActinin is also a FAK substrate and enhances the interaction between FAK and
Src. Additionally, reduction of α-Actinin by siRNA blocks pressure – stimulated
cancer cell adhesion [55]. In the current study, when α-Actinin was reduced by

63
siRNA treatment, paxillin phosphorylation at tyrosine 31 was inhibited. This would
be consistent with a model in which FAK and Src interaction with α-Actinin is
necessary for paxillin phosphorylation in response to pressure.
Finally, to further validate our results that used non – targeting control
siRNA, we found that treatment with scrambled siRNA sequences for paxillin, Crk
and Cas did not influence pressure – stimulated adhesion.
In summary, pressure stimulated colon cancer cell adhesion depends
upon paxillin, and more specifically, upon paxillin phosphorylation at tyrosines 31
and 118. The phosphorylation of paxillin is dependent upon α-actinin and leads to
association with Crk and Cas and downstream activation of Rac1. This pressureactivated pathway seems clinically relevant, as increased extracellular pressure
stimulates colon cancer cell adhesion to endothelial cells in vitro and surgical
wounds in vivo, and has been shown to influence tumor-free survival in a murine
transplantable tumor model [22,41,99]. Although complete delineation of the
pressure-sensitive signal pathway responsible for this effect awaits further study,
paxillin and its binding partners seem critical to the adhesion process and may
offer innovative therapeutic targets.
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CHAPTER 5
NF-kB Dependent Pressure-Induced Proliferation
Extracellular pressure increases of 15mmHg above ambient for 1-30
minutes stimulate β1-integrin binding affinity in suspended cancer cells before
adhesion through FAK, Src and Akt activation, and β1-integrin phosphorylation
[100]. Prolonged pressures of similar magnitude stimulate proliferation in
mesangial cells during glomerular hypertension, cardiac myocytes after
abdominal aortic constriction, and in endothelial cells [101,102,103]. Preliminary
studies from our laboratory demonstrated that 15mmHg increased pressure
stimulates SW620 and HCT-116 colon cancer cell proliferation [31]. In contrast to
the stimulation of cancer cell adhesion by extracellular pressure [100] or the
stimulation of proliferation in Caco-2 cells by cyclic strain [104], the mitogenic
effect of pressure appears independent of Src, but its underlying mechanism is
largely unclear.
Physical forces may activate mitogenic signals varying with the cell and
stimulus studied, including MAPK, Rho GTPases, and integrin activation. Two
prominent candidates to mediate the mitogenic effects of pressure are Rac1 and
NF-kB. Rac1 can be activated by forces such as deformation and pressure, and
can modulate proliferation, adhesion, and migration [105,106]. NF-kB is a rapidly
acting transcription factor that modulates gene transcription in cell-cycle
regulation, apoptosis, and proliferation. NF-kB family members share a Rel
homology domain in their N-terminus. However, RelA, RelB and c-Rel are the
only members with transactivation domains. NF-kB family members form

65
homodimers or heterodimers to participate in transactivation. RelA, the p65
subunit, regulates transcription directly, as it has a nuclear translocation
sequence in addition to a direct DNA binding site. Traditional NF-kB signaling
involves heterodimerization between RelA and p50. NF-kB can promote or inhibit
apoptosis depending upon the stimulus [35]. For example, NF-kB promotes
apoptosis in colon cancer cells treated with aspirin [107]. In contrast, murine B
cell proliferation is suppressed when NF-kB is blocked and constitutive NF-kB
activation in gastric cancer cells promotes proliferation [36,108].
We hypothesized that pressure stimulates cancer cell proliferation via NFkB activation. We measured intratumoral pressure directly in patients to confirm
that pressure was increased within tumors, although we were not able to localize
tumor center or periphery sufficiently to document the intratumoral pressure
gradient observed by others [109]. We examined the proliferative response to
increased extracellular pressure of 3 colon cancer cell lines, a breast cancer line,
and a prostate cancer line. These studies were repeated after treatment with 3
NF-kB inhibitors or NF-kB-specific small interfering RNA (siRNA). We also
evaluated pressure effects on NF-kB nuclear translocation, NF-kB transcription
factor activity, and NF-kB-driven events that can stimulate proliferation, including
IKK and IkB phosphorylation and cyclin D1 expression. We further examined NFkB activity in pressure-treated cells treated with inhibitors of FAK, Akt and Protein
Kinase C (PKC). Finally, we compared IkB phosphorylation, NF-kB, and cyclin D
expression, and proliferation in the relatively lower pressure peripheries and the
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relatively higher pressure centers of 28 large primary tumors to validate our in
vitro findings.
We confirmed previous reports of increased extracellular pressure within
human tumors [110] by measuring interstitial pressure just outside 13 human
intraabdominal malignant tumors and then within them during image-guided
biopsy. Pressures within the tumors were greater than pressures in adjacent
tissue (Figure 20, n=13,p<0.05).
SW620, Caco-2 and CT-26 colon cancer, MCF-7 breast. and PC3
prostate cancer cells were exposed to 0-80mmHg increased extracellular
pressure for 24 hours and proliferative activity was assessed by MTT assay.
Each cell line displayed increased MTT fluorescent intensity across the range of
increased pressures, with greatest responses at 40-60mmHg increased pressure
(Figure 21, n=13;p<0.05). Parallel manual cell counting confirmed increased cell
numbers after exposure to 40 mmHg increased pressure vs. ambient
(n=4;p<0.05, not shown). The Rac1 inhibitor NSC23766 did not prevent
increased MTT fluorescent intensity in pressure-treated cells (Figure 22,
n=4;p<0.05), but the NF-kB inhibitor SN50, an NF-kB nuclear decoy, a novel
imidazoline inhibitor, TCH-021, or NF-kB specific siRNA abolished the effect.
Pressure remained mitogenic in cells treated with an inactive SN50 analog, an
inactive NF-kB nuclear decoy, or a non-targeting control siRNA sequence (Figure
22, n=6;p<0.05). To contrast pressure stimulation of adhesion and proliferation,
SW620 cells were treated with the NF-kB inhibitor SN50 and exposed to ambient
or 40mmHg increased pressure during a 30 minute adhesion assay. Adhesion
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Figure 20. Extracellular pressure in human tumors. Tissue pressure was
measured just outside and within 13 human intraabdominal malignant tumors.
Pressure was increased inside the tumors relative to outside.

Absorbance (460nm) / Control

68

1.4

Control
Pressure

*

1.2

*

*

*

CT26

Caco-2

MCF-7

*

1.0

0.8

0.6

0.4

0.2

0.0

SW620

PC3

Figure 21. Extracellular pressure stimulates the proliferation of various
cancer cell lines. 40mmHg increased pressure (shaded bars) stimulated
proliferation in SW620, CT26 and Caco-2 colon cancer cells, MCF-7 breast
cancer cells and PC3 prostate cancer cells.
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Figure 22. Increased proliferation in response to extracellular pressure is
abolished in the presence of NF-kB inhibitors. Proliferation in response to
40mmHg increased pressure (shaded bars) is blocked in SW620 cells treated
with SN50, a NF-kB nuclear decoy, TCH-021 and NF-kB specific siRNA, but not
after treatment with the inactive SN50 analog, the inactive nuclear decoy or the
Rac1 inhibitor NSC23766.
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increased similarly in both control and NF-kB-inhibited cells (Figure 23,
n=4;p<0.05). To further characterize the effect of increased pressure on cell
cycle regulation, SW620 cells were treated with inhibitors, exposed to 24 hours of
ambient or 40mmHg increased pressure, and cell cycle analysis was performed
by flow cytometry. S-phase fractions increased 22±6% in untreated cells exposed
to increased pressure (Figure 24, n=3;p<0.01). However, pressure did not
increase S-phase fractions in inhibitor-treated cells (Figure 24, n=4;p<0.05).
Finally, TUNEL staining demonstrated that pressure did not alter SW620 cell
apoptosis (Figure 25, n=3;p<0.05).
To determine whether pressure activated NF-kB, we treated SW620 cells
with NF-kB lentiviral reporter particles expressing firefly luciferase and incubated
them under ambient or 40mmHg increased pressure for 24 hours. Pressure
increased NF-kB activation 94±7% (Figure 26A, n=12;p<0.05). However, the NFkB inhibitors SN50 and TCH 021, the NF-kB nuclear decoy, and siRNA to NF-kB
each prevented pressure-associated NF-kB activation (Figure 26A, n=6;p<0.05).
NF-kB activation is typically accompanied by nuclear translocation. We therefore
evaluated NF-kB p50 and p65 levels in nuclear fractions derived from SW620
cells exposed to ambient or 40mmHg increased pressure for 24 hours. p50 and
p65 nuclear translocation increased 58±6% and 67±8% respectively in pressuretreated cells compared to ambient pressure (Figure 26B, n=6;p<0.05).
NF-kB is sequestered within the cytosol by binding its inhibitor IkB. When
IkB is phosphorylated by the kinase IKK, released NF-kB translocates to the
nucleus [35,111]. IKK phosphorylation was increased 27±4% in pressure-treated
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Figure 23. NF-kB inhibition has not effect on pressure stimulated cancer
cell adhesion. 40mmHg increased pressure (shaded bars) increased SW620
cell adhesion on collagen in the presence of SN50 control and SN50 inhibitory
peptide.
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Figure 24. SW620 colon cancer cells increase S-phase fractions in
response to elevated pressure. S-phase fractions increased in SW620 cells
exposed to 40mmHg pressure (shaded bars) after no prior treatment or SN50
inactive peptide treatment. Cells treated with the NF-kB inhibitors SN50, a NFkB nuclear decoy, or TCH-021 showed no increase.
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Figure 25. No changes in apoptosis are observed in pressure treated cells.
TUNEL staining in SW620 cells after treatment with SN50, a NF-kB nuclear
decoy or TCH-021 showed no changes in apoptosis with pressure.
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Figure 26. Effect of increased pressure on NF-kB activity and nuclear
localization. (A) Pressure (shaded bars) increased SW620 NF-kB activity. This
increase was abolished by SN50, a NF-kB nuclear decoy, or TCH-021. (B) NFkB p65 and p50 increased in nuclear fractions from SW620 cells exposed to
increased pressure, using histone H1 as a loading control.
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cells relative to ambient control cells (n=8;p<0.05, not shown). We also observed
a 61±8% increase in IkB phosphorylation in pressure-treated cells compared with
cells at ambient pressure (Figure 27A, n=8;p<0.05). Elevated pressure also
decreased NF-kB-IkB association 31±4% (Figure 27B, n=5;p<0.05). Cyclin D1 is
influenced by NF-kB and regulates the G1-S phase transition [34]. We therefore
compared cyclin D1 expression in SW620 cells at ambient or increased pressure
for 24 hours. Pressure-treated cells expressed 26±5% more cyclin D1 than
ambient pressure controls (Figure 28, n=6;p<0.05). This increase was abolished
in cells pre-treated with the NF-kB inhibitors SN50 or TCH 021, with a nuclear
decoy, or with siRNA to NF-kB (Figure 28, n=5;p<0.05). NF-kB family members
form homo- or heterodimers prior to nuclear localization and transcription factor
activation. Traditional NF-kB signaling involves the p50/p65 dimer. NF-kB p65
and p50 transcription factor activity increased 48±6% and 50±4% respectively in
response to pressure (Figure 29, n=6;p<0.05).
NF-kB activation and subsequent signaling in response to some stimuli
may be influenced by PKC. Go6976, which inhibits both PKC-α and PKC-β, and
a pure PKC-β inhibitor abolished the effect of pressure on proliferation. However,
elevated pressure increased proliferation in cells treated with a PKC-ε
translocation inhibitor, similarly to untreated controls (Figure 30A, n=9;p<0.05).
Inhibiting PKC-α/β in combination, or inhibiting PKC-β alone also abolished NFkB activation in response to pressure (Figure 30B, n=9;p<0.05). FAK and Akt
mediate the effects of extracellular pressure on integrin-mediated adhesion as
well as the stimulation of proliferation by another physical force, cyclic
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Figure 27. Effect of pressure on NF-kB signaling. (A) Pressure (shaded
bars) increased SW620 IkB (serine273) phosphorylation vs. ambient pressure
(open bars), using actin as a loading control. (B) Co-immunoprecipitation
revealed reduced association between NF-kB(p65)/IkB under increased pressure
(shaded bars). Total NF-kB was a loading control.
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Figure 28. Cyclin D1 expression increases in response to pressure. SW620
cyclin D1 expression increased after exposure to increased pressure (shaded
bars). This increase was abolished by SN50, a NF-kB nuclear decoy or TCH021. Actin was a loading control.
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Figure 29. Extracellular pressure increases NF-kB p65 and p50
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p65 transcription factor activity in SW620 nuclear fractions relative to ambient
controls.
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and NF-kB activation. (A) Inhibiting PKC-β or PKC α/β abolished pressurestimulated proliferation. PKC-ε inhibition did not. (B) PKC-β and PKC α/β
inhibition blocked the effect of increased pressure on NF-kB activation. PKC-ε did
not.
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deformation [100]. However, inhibition of FAK or Akt did not prevent the
mitogenic effects of pressure on NF-kB activation, unlike global PKC inhibition
using calphostin C (Figure 31, n=9;p<0.05). The IKK complex is required for IkB
phosphorylation and subsequent NF-kB activation. To evaluate the effect of IKK
subunits on pressure-stimulated NF-kB activation, we treated SW620 cells with
inhibitors to IKK-2 or IKK-3, or an IKK inhibitor that blocks IkB phosphorylation.
Individually, these inhibitors did not prevent pressure activation of NF-kB (Figure
32A, n=12;p<0.05). However, when IKK-2 and IKK-3, or IKK-2 and the IkB
phosphorylation were blocked together, pressure activation of NF-kB was
abolished. Pressure-induced NF-kB activation was also reduced when all three
inhibitors were combined (Figure 32B, n=12;p<0.05).
Since extracellular interstitial pressures are higher in the center of many
solid human tumors than at their peripheries [109,110], we compared mitotic
rates at the periphery and center of 28 human colon, lung, and head and neck
tumors, averaging 8±1.2cm diameter. A reviewer blinded to the hypothesis
reported a 154±14% increase in mitotic figures/high power field in the central
regions of the tumors relative to their peripheries (Figure 33, n=15;p<0.05).
Parallel studies demonstrated very high immunoreactivity for active NF-kB,
phosphoIkB, and cyclin D1 in the centers of these tumors which decreased
towards their peripheries. Little or no staining was observed in adjacent nonmalignant

tissues

from

each

specimen

(Figures

34-36,

n=27;p<0.05).

Assessment of immunoreactivity on a scale from 0 (negative staining) to 4 (high
staining), specimens immunostained for NF-kB were scored in 95 zones from
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Figure 31. Effect of FAK, Akt and PKC inhibition on pressure-stimulated
proliferation. Inhibiting FAK and Akt did not affect pressure-induced NF-kB
activation, but PKC blockade abolished the effect.
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Figure 32. IKK inhibition affects pressure stimulated NF-kB activation in
combination. (A) Inhibitors of IKK-2, IKK-3 and IKK phosphorylation of IkB did
not reduce pressure-stimulated NF-kB activation when used individually. (B)
Combination of IKK-2 and IKK inhibitor of IkB phosphorylation abolished
pressure-stimulated NF-kB activation, as did IKK-2 and IKK-3, or all three
inhibitors together.
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Figure 33. NF-kB immunostaining increases in the center of human
tumors. Immunohistochemical staining of colorectal carcinomas, representative
of staining observed in colorectal, head and neck and lung tumors. To obtain a
full view of the sample, a panel of photographs were taken and placed together.
Dashed lines represent zones of overlap within the image. Panel images were
taken at 4X magnification and images within each zone at 20X. Staining
represents active NF-kB.
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Figure 34.
Phospho-IkB staining in the center of human tumors.
Immunohistochemical staining of colorectal carcinomas, representative of
staining observed in colorectal, head and neck and lung tumors. To obtain a full
view of the sample, a panel of photographs were taken and placed together.
Dashed lines represent zones of overlap within the image. Panel images were
taken at 4X magnification and images within each zone at 20X. Staining
represents phospho-IkB.
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Figure 35.
Cyclin D1 staining in the center of human tumors.
Immunohistochemical staining of colorectal carcinomas, representative of
staining observed in colorectal, head and neck and lung tumors. To obtain a full
view of the sample, a panel of photographs were taken and placed together.
Dashed lines represent zones of overlap within the image. Panel images were
taken at 4X magnification and images within each zone at 20X. Staining
represents cyclin D1.
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Figure 36. Mitotic index increases in the center of human tumors. Mitotic
index increases in tumor centers vs. peripheries. Non-malignant tissue showed
minimal staining and few mitotic figures.
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adjacent histologically normal margins from 19 different tumor samples and
averaged a score of 0.8. Blinded evaluation of areas at the periphery of the
tumors in these same slides yielded a mean score of 2.2, while central tumor
zones received a mean score of 3.6. Similar gradients occurred for phospho-IkB
and cyclin D1 immunoreactivity (Table 3). Differences between the normal tissue,
the peripheral zone, and the central tumor zone were each statistically significant
(p<0.01). Mitotic figures were separately counted in 20 fields of highly NF-kBimmunoreactive

areas

within

the

tumors

compared

to

less

NF-kB-

immunoreactive areas, confirming a 124±8% increase in mitotic figures within
these more immunoreactive zones (p<0.05, not shown).
Tumor cells are exposed to increased extracellular pressure during
passage through the circulatory and lymphatic systems [65,112]. Intraabdominal
pressures can reach 15-30mmHg post-operatively as fluid is sequestered within
the extracellular space of the viscera, causing swelling against the abdominal
wall [113]. Although we and others have suggested that increased extracellular
pressure can stimulate cancer cell proliferation, the mechanism has been
unknown [31,114]. Cells respond to numerous mitogenic intracellular signals,
including Src, FAK, MAPK, and Rac1. However, blocking Src, FAK or the MAPK
does not prevent the mitogenic effects of pressure [31,115], and blocking Rac1
did not inhibit the mitogenic effects of pressure here. In contrast, NF-kB is a
transcription factor that in some instances can be pro-apoptotic and in others
mitogenic, depending on the stimulus and setting [34]. Our data suggests that
increased extracellular pressure stimulates cancer cell proliferation through

88

Table 3. Immunohistochemical Scores
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PKCα/β-dependent IKK and IkB phosphorylation, NF-kB activation and nuclear
translocation, and increased cyclin D1 expression.
Mitogenic signaling in response to forces such as pressure may influence
the proliferation of many cell types [17,31,116]. Less than 5mmHg of pressure
stimulates

endothelial

proliferation,

while

70mmHg

pressure

increases

osteosarcoma proliferation and 160mmHg stimulates aortic myocyte proliferation
[65,103,117]. In contrast, neuronal cell lines display apoptosis after 2 hours of
100mmHg increased pressure, and 40-80mmHg pressures increase human
mesangial cell proliferation, while pressures of 100-180mmHg stimulate
apoptosis in the same cells [118,119]. Although these results support an effect of
pressure on proliferation in some cell types, how this occurs has not been
elucidated. Several theories have been advanced. Some have hypothesized that
pressure-exposed cells secrete a factor into the medium that influences
proliferation, while others suggest that the disruption of the attachment between
integrins and the cytoskeleton is responsible [114]. Additionally, non-malignant
cells seem to respond to a lesser stimulus than their malignant counterparts, and
malignant cells seem to have a threshold by which a proliferative response to
pressure may turn apoptotic [103,117]. This study focused on pressures within
the range typically experienced by tumor cells in vivo, and found that such
pathophysiologically relevant pressure increases stimulate the MTT-based
reduction

of

3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium

bromide

to

formazan, and increase S-phase fraction and cell numbers in colon, breast and
prostate cancer cells. Apoptosis did not change. Taken together, these results
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strongly suggest that pressure increases cell number by stimulating proliferation,
rather than inhibiting apoptosis.
Previous studies suggest that pressure stimulates the adhesion of
suspended cancer cells to matrix proteins, endothelial cell monolayers and
surgical wounds in a manner that depends upon an intact cytoskeleton, as well
as PI-3-kinase and Src signaling [100]. However, the pathway by which pressure
stimulates proliferation seems different from the signaling mediating pressurestimulated adhesion, because in the previous preliminary study the mitogenic
effects of pressure were not prevented by inhibiting Src or PI-3-kinase, or the
actin stablilization agent phalloidin, although these each prevent pressure
stimulation of adhesion in suspended cells [31,100]. Our current study further
confirms that pressure stimulates adhesion and proliferation by different
pathways, and that pressure acts differently from repetitive deformation. Rac1 is
required for pressure-stimulated adhesion [105] and the mitogenic effects of
repetitive deformation in human Caco-2 colon cancer cells and non-malignant
IEC-6 intestinal epithelial cells [120] but does not seem to contribute to the
mitogenic effects of pressure. The differences between those previous
observations and the present data likely reflect differences in the signaling of
cancer cells not yet adherent to matrix proteins (thus lacking a background of
integrin-driven intracellular signaling) and in the responses to constant pressure
compared with cyclic deformation.
NF-kB signaling is complex, and can promote proliferation through
increased expression of cell cycle regulators, or cell death through interactions
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with anti-apoptotic factors such as FLIP and TRAF1/2 [34]. NF-kB is activated in
response to deformation. Mechanical stretch activation of NF-kB in muscle cells
increases TNF-alpha and IL-1B expression, while osteoblast-like MF-63 cells
display NF-kB activation in response to low amplitude cyclic strain, but not low
amplitude compressive strain. Interestingly, this effect was reversed at high
amplitude cyclic and compressive strain [121,122]. High pressures can also
activate NF-kB [123]. In our current study, pressure stimulated NF-kB nuclear
translocation of the p50 and p65 subunits, as well as NF-kB activation. This
occurred through phosphorylation of the IKK complex and subsequent IkB
phosphorylation.

NF-kB

activation

increased

cyclin

D1

expression

and

proliferation.
FAK and Akt are necessary for pressure-induced adhesion and the
mitogenic effects of repetitive deformation [100], and also often mediate NF-kB
activation [124,125]. However, inhibition of FAK or Akt did not prevent pressure
activation of NF-kB here. Conversely, some PKC isoforms can also influence NFkB activation and proliferation. Controversy exists over whether PKC-α or PKC-ε
mediates NF-kB activation in T cells [126,127]. In colon cancer cells, PKC-τ has
been reported to regulate NF-kB [128]. In our study, inhibiting PKC-β or PKC α/β,
but not PKC-ε, prevented pressure activation of NF-kB. Intestinal epithelial
proliferation in response to strain depends on PKC-α which, like PKC-β, requires
calcium for activation [129]. In contrast, PKC-ε is representative of the calciumindependent family. The role of calcium in pressure-mediated proliferation awaits
further study.
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The IKK complex is responsible for IkB phosphorylation and subsequent
NF-kB activation. TNF-α is required to activate this complex. The IKK-2 inhibitor
we used is reported to function by inhibiting TNF-α production, while the IKK-3
inhibitor is an ATP-competitive inhibitor. The global IKK inhibitor is thought to
block IkB phosphorylation directly. The roles of the IKK isoforms are diverse and
vary with cell type. IKK-2 is necessary for myeloma cell proliferation, but IKK-2
deletion increases myocyte proliferation [130,131]. Although the individual
inhibitors of IKK-2, IKK-3 and IKK phosphorylation of IkB did not prevent
pressure activation of NF-kB, using these inhibitors in combination blocked this
effect, indicating pathway redundancy but confirming IKK relevance.
Aberrant or constitutive NF-kB activation characterizes many human
malignancies and indicates poor prognosis in colorectal and esophageal cancers
[34,36,37]. We observed intense NF-kB, IkB, and cyclin D1 immunoreactivity in
the high pressure center of the tumors which was reduced towards the lower
pressure periphery and virtually absent in the adjacent normal tissue. These
were all solid tumors without significant necrosis, which could have affected
intratumoral pressures. NF-kB immunoreactivity of this magnitude correlates with
poor prognosis [38]. Correlation does not prove causation, but our observations
in human tumors suggest at least a potential causal link between pressuremediated NF-kB activation and increased proliferation in tumors that is further
supported by our in vitro mechanistic studies.
In conclusion, pathophysiologically relevant increases in pressure
stimulate colon, breast and prostate cancer cell proliferation by a mechanism
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involving activation of PKC and the IKK complex, and NF-kB p50 and p65
nuclear localization and activation, and increased cyclin D1 expression. This
effect may explain, in part, the increased NF-kB, IkB and cyclin D1
immunoreactivity and increased proliferation that we observed within the higher
pressure centers of human tumors. Tumor growth involves numerous signaling
cascades. These results suggest that the increases in extracellular pressure
generated by tumor growth and stiff tumor matrix may themselves stimulate
proliferation within the tumor, generating a positive feedback loop. This pathway
may represent a target of opportunity to slow the growth of unresectable tumors
in patients and tumors not candidates for conventional cytotoxics.

CHAPTER 6
Pressure-Induced Metastatic Signaling In Vivo
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We hypothesized that cancer cells are activated by the increased
pressures and shear forces of the circulation, leading to increased adhesion and
metastasis, and that blocking this activation can reduce metastasis.
It has been estimated that nearly 1 X 106 tumor cells per gram of tumor
tissue are shed into the bloodstream each day [132]. In addition, viable tumor
cells can be recovered from the peripheral blood of more than 40% of patients
immediately following “curative” colon tumor resection surgery, indicating a poor
prognosis [133,134]. Such circulating cancer cells encounter many host
responses, including immune system interference, but some surmount these
hurdles and progress to metastatic disease.
0.8-1.0% of patients may experience wound implantation following tumor
resection surgery, while laboratory studies suggest that CT-26 murine colon
cancer cells exposed to 30 minutes of 15mmHg increased pressure adhere to
surgical wounds significantly greater than those cells left in ambient pressure
conditions [135,136]. However, although local surgical site recurrence can be an
important adverse event, most metastasis occurs via distant spread through the
lymphatic, venous, and arterial circulation [137]. Such metastatic progression
depends upon tumor cell adhesion at a distant site, but the factors that influence
cancer cell adhesion are incompletely understood. Some studies suggest that
adhesion at a distant site is a completely random process, while others have
implicated the overexpression of adhesion molecules such as ICAM, E-Cadherin,
or integrins [138,139]. Increased extracellular pressure promotes cancer cell
adhesion in vitro by FAK and Src activation at the focal adhesion complex, Akt
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activation, and ultimately increased β1 integrin binding affinity [100]. Shear stress
similarly promotes adhesion in vitro [46]. These findings seem potentially
clinically relevant, as cancer cells experience pressure and shear stresses as
they circulate.
To test our hypothesis, CT-26 murine colon cancer cells were labeled with
carboxyfluorescein succinimidyl ester (CFSE) and 1 million cells were injected
into the tail vein of Balb/c mice. After 30 minutes, the cells were recovered by
cardiac puncture and analyzed by flow cytometry. The flow cytometer gated only
fluorescent CFSE labeled tumor cells that were further evaluated for FAK, Akt
and 9EG7 phosphorylation or activation. Passage through the circulation
increased phosphorylation of FAK at tyrosine 397 and Akt at serine 473, similar
to that observed in vitro in response to increased extracellular pressure.
Activation of the 9EG7 epitope, which specifically indicates activation of β1
heterodimers, was also increased in cells recovered from the circulation (Figure
37, n=6;p<0.05). Pretreatment with pharmacologic inhibitors to FAK or Akt
prevented the increased phosphorylation of these molecules (not shown).
Pressures of the portal circulation are much lower (5-10mmHg) than those
of the peripheral circulation (120-125mmHg) [140,141]. We first sought to
determine whether pre-treating cells with pressure before injection into the portal
circulation could increase adhesion and metastatic capability from within blood
vessels. We exposed luciferase tagged CT-26 cells to ambient or 15 mmHg
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Figure 37. Pressures of the systemic circulation activate signaling in
circulating cancer cells. Effect of circulatory pressures on β1 integrin
heterodimer 9EG7 activation, FAK tyrosine 397 phosphorylation and Akt serine
473 phosphorylation. Data from individual experiments were normalized to their
individual control. MFI, mean fluorescent intensity.

increased pressure and injected 750,000 cells into the spleen of Balb/c mice.
Seven days later, we injected the mice with luciferin and imaged them using a
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Kodak IS4000MM small animal imaging device. Exposure conditions were held
constant for all measurements and all bioluminescence intensity of the images
were pseudocolored (pink-low intensity; red-highest intensity). Quantitation using
MetaMorph software indicated a 73±6% increase in luminescence in the spleen
and liver of mice injected with pressure pre-treated cells relative to ambient
controls (Figure 38, n=16; p<0.05). Splenic weight increased 62±9% and hepatic
weight 41±11% in mice receiving pressure pre-treated cells (Figure 39,
n=16;p<0.05), and long term survival was substantially decreased in mice
injected with pressure pre-treated cells compared with mice injected with cells
not first exposed to increased pressure (Figure 40, n=20; p<0.05). Prior
treatment of the cells with inhibitors of FAK or Akt before pressure treatment and
splenic injection resulted in reduced luminescence in mice receiving cells not
exposed to increased pressure and blocked the increase in luminescence
associated with injection with pressure-treated cells (Figure 41). Furthermore,
long term survival increased substantially in mice receiving inhibitor-treated, with
or without pressure pre-treatment (n=20 for each inhibitor; p<0.05, Figure 40).
To distinguish alterations in adhesion from any effect of this single dose of each
inhibitor on cellular proliferation, we performed MTT assays on cells treated with
the FAK or Akt inhibitor. We observed an initial decrease in cell proliferation with
each inhibitor, but a full recovery in proliferation by 24 hours compared with
untreated cells (Figure 42, n=5;p<0.05). Since we imaged the mice seven days
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Figure 38. 15 mmHg increased pressure stimulates local metastasis via
splenic injection. Splenic and hepatic tumor burden was visualized using
luminescence following splenic injection with ambient or pressure pre-treated
luciferase tagged CT-26 cells.
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Figure 39. Splenic and hepatic weights following splenic injection. Splenic
and hepatic weights were measured following splenic injection with ambient or
pressure pre-treated CT-26 cells. Cardiac weight was used as a control.
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Figure 40. Long term survival following CT-26 splenic injection. Long term
survival was measured in mice following splenic injection of CT-26 cells pretreated with ambient or pressure conditions, or CT-26 cells pre-treated with FAK
or Akt inhibitors prior to exposure to ambient or increased pressure conditions (*
indicates p<0.05; ** indicates p<0.01).
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Figure 41. Splenic and hepatic burden following FAK or Akt inhibition.
Splenic and hepatic tumor burden was visualized using luminescence following
splenic injection of CT-26 cells pre-treated with FAK or Akt inhibitors prior to
exposure to increased or ambient pressure.
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Figure 42. Cellular proliferation following treatment with FAK or Akt
inhibitors. An MTT assay was performed on CT-26 cells following treatment
with FAK or Akt inhibitors (* indicates p<0.05; ** indicates p<0.01).
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after surgery, our findings are thus more likely to reflect modulation of initial
tumor cell adhesion than interference with cellular proliferation.
To further confirm that cancer cells become activated during transit
through the circulation, we exposed luciferase tagged CT-26 cells to ambient or
15 mmHg increased pressure for 30 minutes and injected 1 million into the tail
vein of Balb/c mice. Seven days after surgery the mice were injected with
luciferin and bioluminescent imaging was performed. In contrast to our results
with portal injection, we observed no increase in lung metastasis in mice
receiving pressure pre-treated cells relative to those receiving control cells
preincubated at ambient (Figure 43, n=20) and we found no difference in long
term survival (Figure 44, n=20), consistent with our observation (Figure 37) that
the force-activated pathway was already activated by passage through the
circulation. When we pre-treated the cells with FAK or Akt inhibitors to block this
pathway, lung metastasis was reduced (Figure 45, n=12) and long term survival
increased (figure 44, n=12).
Cancer metastasis is a complex process. Increased expression of cell
surface receptors such as VEGF, loss of function of tumor suppressor genes
such as p53 and over-expression of oncogenes all contribute [142]. Our results
suggest that the extracellular forces experienced by cancer cells during
circulation activate an adhesiogenic pathway that promotes adhesion and
subsequent metastasis. Cells pretreated with increased pressure displayed
increased adhesion and tumor burden locally, as illustrated by our splenic
injection model. However, because pressure activation is already maximized as
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Figure 43. Metastasis of circulating tumor cells. Lung metastasis following
tail vein injection of CT-26 cells exposed to 15 mmHg increased or ambient
pressure.
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Figure 44. Long term survival following CT-26 tail vein injections. Long
term survival of mice following tail vein injection of CT-26 cells pre-treated with
15mmHg increased or ambient pressure, or pre-treated with FAK or Akt
inhibitors.
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Figure 45. Lung metastasis following tail vein injection of inhibitor treated
or untreated cells. Lung metastasis was reduced following treatment with FAK
or Akt inhibitors.
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cancer cells travel through the circulation, pretreatment with pressure did not
further increase lung metastasis in our tail vein model.
Previous studies have confirmed the importance of FAK and Akt activation
in pressure induced signaling in vitro, as well the necessity of a dynamically
functional cytoskeleton [100]. FAK is a critical regulator in the signaling by which
pressure stimulates adhesion, proliferation and migration of cancer cells. In vitro
studies suggest that increased pressure results in FAK phosphorylation and
activation and downstream signaling. Furthermore, FAK and Akt may participate
in bi-directional signaling where FAK is necessary for Akt activation and Akt is
necessary for FAK activation. Upon activation, FAK and Akt translocate to the
cell membrane where FAK associates with β1 integrin. This association
increases in response to elevated pressures leading to increased integrin affinity
[100,136]. Although this novel mechanism has been previously elucidated in
vitro, this is the first demonstration that physical forces promote metastasis in
vivo, and that interruption of the force-activated signal pathway has biological
consequences for metastasis.
In the present study, pretreatment of the cancer cells with a single dose of
an inhibitor of FAK or Akt, critical kinases activated by physical forces, decreased
metastasis and increased long term survival. FAK or Akt expression is increased
in diverse tumors, including those of colon, breast, prostate and lung [143,144].
Increased FAK expression correlates with increased cancer cell migration,
invasion, and metastasis [144,145]. Akt stimulates aerobic respiration in cancer
cells [146]. Akt activation and localization correlates with tumor invasion,
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oncogene expression and an overall poor prognosis in several cancers, including
thyroid, lung and endometrial [147]. Early stage clinical trials of chronic therapy
with FAK or Akt inhibitors have shown promise. TAE226 is a FAK inhibitor that
inhibits cell proliferation and migration, induces apoptosis and inhibits cancer cell
growth through inhibition of FAK tyrosine 397 phosphorylation. Another FAK
inhibitor PF-562,271 inhibits FAK autophosphorylation and has lead to tumor
regression or stable disease in ovarian cancer patients when taken daily [148].
Similarly, the Akt inhibitors KP372-1 and GSK690693 inhibit tumor cell growth
and proliferation and induce apoptosis in a variety of cancers with daily treatment
[149].

Although

such

trials

imply

a

potential

benefit

of

these

new

chemotherapeutic agents as part of a daily, long term regimen, our current
results suggest that even a single perioperative dose of these inhibitors may
interfere with perioperative tumor dissemination and metastasis when tumor cells
are shed during surgery.
In conclusion, our results indicate that in vivo pressures modulate cancer
cell adhesion and metastasis. Cancer cells traveling through the circulation
experience phosphorylation of FAK and Akt leading to activation of signaling that
induces adhesion. Increased adhesion at a distant site perpetuates the
metastatic process and indicates a poor prognosis for patients. These findings
may be particularly relevant, to patients with unresectable tumors or patients
undergoing surgery in whom millions of cancer cells may be shed from a primary
tumor prior to and during its removal.
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CHAPTER 7
Discussion
Molecular signaling events that mediate cancer cell adhesion and
proliferation are clinically relevant and necessary for our understanding of the
metastatic process as well as inside out signaling. These results demonstrate
that pressure activation of cancer cells influences tumor cell adhesion, and by a
different mechanism, cellular proliferation. Furthermore, our results demonstrate
the effect of pressure in vivo and potential targets to reduce metastatic events.
We have shown that pressure induces adhesion in colon and breast
cancer cells.

Colon cancer cell adhesion is dependent upon paxillin

phosphorylation at tyrosines 31 and 118. Phosphorylation at these sites activates
a signaling cascade inducing Rac1. Further evidence suggests paxillin signaling
involves alpha-actinin, FAK and Src, and illustrates at least a partial working
model by which physical forces may be translated into biochemical signals
modulating integrin activation and cell adhesion.
In addition, our findings demonstrate the diverse pathway by which
pressure induces cancer cell proliferation. Previous studies from our laboratory
have shown that pressure stimulated adhesion is dependent upon Src, Akt and
an intact cytoskeleton, however, pharmacological disruption of these molecules
had no effect on pressure induced proliferation. Our current study elucidated a
pathway by which pressure activates NF-kB, increasing transcription factor
activity and proliferation. Furthermore, immunohistochemical staining confirmed
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increased NF-kB staining intensities in the high pressure center of human tumors
relative to the periphery.
Finally, we have shown the effect of pressure in vivo using a local and
systemic metastasis model.

Our findings confirm that cancer cell activation

occurs as cells experience pressure changes while traveling through the
circulation.

Disruption of the signaling that mediates pressure stimulated

adhesion was shown to reduce tumor burden and increase long term survival.
Taken together, these results indicate two diverse signaling mechanisms
by which pressure mediates adhesion as well as proliferation. Elucidation of the
final kinases regulating these mechanical signaling pathways, as well as
redundancies within the pathways, may provide additional targets for therapeutic
intervention, and thus merits further study. Although we have found that NF-kB
is not necessary for pressure-induced adhesion, we have yet to determine its
relevance in vivo. In addition, further investigation is needed to evaluate the role
of calcium in this mechanical signaling study, as calcium dependent protein
kinase C seems to be necessary for pressure-induced proliferation, but not
calcium independent isoforms.

Full elucidation of this pathway may provide

molecular targets to inhibit metastasis in disseminated tumor cells following
curative tumor resection surgery and potentially improve overall survival.
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Increased extracellular pressure stimulates cancer cell adhesion by a
mechanism that is dependent upon β1-integrin activation, an intact cytoskeleton,
and FAK and Src activation. By a different mechanism, increased extracellular
pressure modulates cancer cell proliferation in a manner that is regulated by
protein kinase C, but not Src or an intact cytoskeleton. Previous studies from our
laboratory have shown that paxillin is a necessary mediator in the pathway by
which pressure stimulates adhesion; however, it had not been determined
whether paxillin acts simply as a scaffold, or participates in diverse signaling
events. I therefore hypothesized that paxillin phosphorylation mediates pressure
stimulated adhesion and further asked whether the independent pathway by
which pressure induces proliferation is modulated by NF-kB. Finally, I postulated
that increased pressures of the circulation activate cancer cells to increase
adhesion, proliferation and overall tumor burden in vivo. My data illustrate that
paxillin phosphorylation at tyrosines 31 and 118 is necessary for pressure
stimulated adhesion, but tyrosine 81 phosphorylation is not. The phosphorylation
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events at tyrosine 31 and 118 form a docking site for the adaptor molecule Crk,
which has a binding site for the highly phosphorylated molecule Cas.

Each

member of the paxillin/Crk/Cas complex is necessary for pressure stimulated
adhesion.

Furthermore, this complex promotes the activation of the small

GTPase, Rac1.
Next, I evaluated whether Rac1 was necessary for pressure induced
proliferation, and found that it is not. However, it was found that this pathway is
dependent upon NF-kB activation. Increased extracellular pressure increases
NF-kB activation in colon, breast and prostate cancer cells. This increase is
abolished in the presence of NF-kB inhibitors.

Further studies showed that

increased pressure activates protein kinase C α/β, increases IKK and IkB
phosphorylation, cyclin D1 expression and increased S-phase fractions.
Immunohistochemical staining for NF-kB, IkB and cyclin D1 increased in the high
pressure center of human tumors and decreased toward the periphery.
Finally, I determined that increased pressures of the circulation activate
cancer cells in vivo by phosphorylation of β1 integrin, FAK and Src.

Pre-

treatment with pressure prior to systemic injection did not increase metastasis.
However, in a local metastasis model, increased tumor burden and decreased
long term survival occurred when cells were pre-treated with pressure. These
increases were abolished when cells were pre-treated with FAK or Akt inhibitors
prior to injection.
In summary, my data suggests pressure activation of malignant cells
promotes tumor development and impairs tumor free survival.

Preoperative
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inhibition of paxillin, NF-kB, or other interventions aimed at blocking pressureinduced integrin activation may abolish this effect.
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